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Abstract 
Metal chelating polymers are functional polymers that bear specified chemical groups 
capable of selectively binding metals. Heavy metal contamination is considered a 
serious problem because these metals, even at relatively low concentration, could 
accumulate in the human body and cause damage to vital organs. Although, some of 
these metals like iron, zinc, and manganese participate in controlling various 
metabolic and signaling pathways, an excess amount of these metals could still lead 
to toxicity and detrimental side effects.  
Metal chelating polymers are frequently used as chelating agents when treating 
metal toxicity such as iron overload diseases. Siderophores are small, high-affinity 
iron chelators secreted by microorganisms such as bacteria. The objective of this 
thesis was to emulate the high affinity, siderophore-mediated iron uptake system of 
bacteria by mimicking the structure of naturally occurring siderophores, such as 
enterobactin. First, polyallylamine (PAAm) hydrogels containing 2,3 
dihydroxybenzoic acid (2,3 DHBA), a portion of the metal chelating domain of 
enterobactin, were synthesized as a potential non-absorbed chelator for iron in the 
gastrointestinal tract. Next, a series of polymeric chelators with various 
hydrogel:DHBA ratios were prepared. PAAm hydrogels were also synthesized and 
further modified by conjugating thioglycolic acid (TGA) and DHBA. These 
hydrogels were utilized for the removal of toxic metal ions such as Pb, Cd and As 
from aqueous environments. The rapid, high affinity binding of toxic metals by these 
functionalized hydrogels offers potential applications in waste water treatment and 
ii 
 
may enable applications in acute metal poisoning.  Finally, a unique synthetic 
methodology using similar metal chelating polymers for synthesizing magnetic 
nanoparticles offered potential for contrast-enhanced magnetic resonance imaging or 
drug delivery. In summary, polymers offer an attractive platform for mimicking 
siderophore structure which provides new approach for applications in medicine 
explored here. 
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Chapter 1 
Metal Chelating Polymers  
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1.1 Background 
Metal chelating polymers are functional polymers that bear specified chemical groups 
capable of selectively binding metals. A metal chelating polymer contains 
coordination sites (e g. nitrogen, oxygen or sulphur) obtained either by the 
polymerization of monomers possessing the desired site or by grafting a low 
molecular weight compound having  high affinity for target ions.
1
 These coordination 
sites or ligands are usually symmetrically oriented or flexible enough to interact with 
metal ions through coordinate or coordinate-covalent bonds.
2
 
Environmental contamination with heavy metal ions is a serious problem. It is 
mostly because of the tendency of these metals to accumulate in living organisms, 
which can lead to toxicity and side effects at relatively low concentration.  Although, 
many studies have reported the toxic and carcinogenic effects of metals in humans 
and in animals, it is also well known that many metals participate in normal 
biological functions of cells.
3
 Several essential transition metals like copper, zinc, 
iron and manganese participate in controlling various metabolic and signaling 
pathways. However, the excess amounts of these metals have reportedly caused 
toxicity in humans. In most cases the excess or free metal could escape the control 
mechanism such as transport, homeostasis, compartmentalization and binding to 
designated cell constituents. This may result in disturbing protein function by 
displacing other metals from their natural binding sites. Such events do not occur 
normally, but such misplacement of metals can lead to malfunctioning of cells and 
lead to side effects or toxicity.
3
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Oxidative stress is one of the major mechanisms behind heavy metal. Metals are 
capable of interacting with nuclear proteins and DNA causing oxidative deterioration 
of biological macromolecules. Metals like iron, copper, cadmium, mercury, nickel, 
lead and arsenic possess the ability to generate reactive radicals, resulting in cellular 
damage. These reactive radical species include a wide variety of oxygen-, carbon-, 
sulfur- and nitrogen- radicals, originating not only from superoxide radical, hydrogen 
peroxide, and lipid peroxides but also from chelates of amino-acids, peptides, and 
proteins complexed with the toxic metals.
3
 These metals generate reactive species 
which may cause neurotoxicity, hepatotoxicity and nephrotoxicity in humans and 
animals.
3
 
Metal chelating polymers play important roles in the function of some living 
organisms. Metalloenzymes are polymer–metal complexes present in nature, where 
metal ions are surrounded by a “chelating polymer”, a large protein molecule with 
three-dimensional structure. A typical example of such a metalloenzyme whose 
structure has been determined is plastocyanin, an important copper-containing protein 
involved in electron-transfer (Figure 1-1). Metal binding polymers are vital for 
human life. For example, they mediate oxygen transport throughout the body within 
hemoglobin, the iron-containing oxygen-transport metalloprotein in the red blood 
cells of vertebrates. Moreover, metal chelates play an essential role in the chemistry 
of chlorophyll, a vital organ for photosynthesis which allows plants to obtain energy 
from light (Figure 1-2). 
 
3 
 
 
Figure 1-1: The copper site in plastocyanin, with the four amino acids that bind the 
metal labeled.
4
  
 
A B
 
Figure 1-2: A: The Fe site in hemoglobin and B: Mg site in chlorophyll.
5-6
  
 
Biomimetic polymers are designed to mimic the structure of a desired biological 
substance. Such polymers can be exploited in various materials, which have the 
potential to enable unique applications in industry including biomedical implants, 
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robotic elements, adaptive protective clothing, and orthopedic devices with 
controllable characteristics.
7
 Many metal chelating polymers have been biologically 
inspired and are being investigated in medicine. Apart from the biomedical field, 
metal chelating polymers also play an increasingly important role in chemical 
industries.
8-9
  
1.2 Application of Metal Chelating Polymers in Medicine 
Appealing physical and chemical properties of polymers make them promising 
materials for use in medical devices and drug delivery systems Polymer-based 
biomaterials have been successfully used in artificial organs, in tissue engineering, 
and as components of medical devices. Moreover, polymers have been utilized in 
drug delivery for small molecule, proteins, and plasmid DNA and siRNA.
10-11
. 
Chelating polymers have garnered significant attention for pharmaceutical application 
in recent years.
12-13
 
Polymers are not usually considered active pharmaceutical ingredients. It is 
obvious that polymers generally do not fit to the traditional definition of “drug-like” 
substances. A unique characteristic of functional or biomimetic polymers suggests 
that polymers might offer a number of beneficial features that are not present in 
traditional small molecule therapies. One of these important features is their high 
molecular weight which makes them interesting for oral drug delivery because of the 
limit of absorption through the gastrointestinal (GI) tract.  
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1.2.1 Chelating Polymers for Selective Recognition of Dietary Phosphate 
 
The kidney is the primary route for removal of excess phosphate from the body. As a 
result, patients with impaired kidney function accumulate phosphate systemically 
leading to elevated plasma phosphate. This may lead to disease conditions like soft 
tissue calcification (leading to cardiac complications), renal bone disease leading to 
reduced bone density, and secondary hyperparathyroidism.
14-15
 
 Phosphate binding therapy has been the primary treatment to manage elevated 
phosphorous in these hyperphosphataemic patients. Traditional phosphate binders 
include metal salts, such as those based on calcium, aluminum, lanthanum and iron.
16
 
These metal salts remove phosphate from the human body through the formation of 
insoluble phosphate salts. However, due to their propensity for systemic absorption, 
long-term use of metal salt derived phosphate binders can lead to undesirable toxic 
side effects leading to neurological disorders (with aluminum) and soft tissue 
calcification (with calcium).  
Researchers then introduced non-absorbed phosphate sequestrants which provided 
safer treatment for managing elevated serum phosphorous in patients experiencing 
renal failure. These polymers are typically cationic hydrogels, containing amines 
and/or guanidinium functional groups that exhibit affinity towards phosphate ions 
derived from dietary sources.
17-18
 Being non-absorbed, they act as effective local 
therapeutic agents (free from the side effects associated with calcium and related 
phosphate binders based on metal salts) for the treatment of hyperphosphatemia. The 
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divalent (and possibly trivalent) nature of phosphate anions requires accessible 
ammonium groups to provide strong binding of the free phosphate through chelation 
(Figure 1-3). 
 
Figure 1-3: Binding of phosphate anions to ammonium and guanidinium hosts. 
Reprinted permission from Elsevier.
19
 
 
 
Cross-linked, metabolically stable polyamines were introduced later as phosphate 
binders. These hydrogels offer inherent safety advantages because they are confined 
to the GI tract. The amino functional polymers bind phosphate anions through 
electrostatic and possibly through hydrogen bonding interactions (Figure 1-4). In 
1998, cross-linked polyallylamine was introduced as a candidate for subsequent 
preclinical and clinical development.
20
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Figure 1-4: Binding interactions between polymeric ammonium compounds and 
phosphate anions. Reprinted with permission from Elsevier.
19
 
 
Cross-linked polyallylamine was approved in the United States by the FDA under 
the generic name of sevelamer hydrochloride, which was then marketed under the 
brand name Renagel®. Since its approval, Renagel® has demonstrated effective and 
long-term control of serum phosphate levels in patients with renal failure. 
1.2.2 Chelating Polymers as Cholesterol-lowering Agents 
 
Elevated levels of serum total cholesterol and low-density lipoprotein cholesterol 
(LDLc) are the primary underlying causes for the development of cardiovascular 
diseases.  The most common treatments for this aim to reduce and control elevated 
LDLc in the serum.
21
 The most widely used cholesterol lowering drugs belong to the 
class of compounds called statins; however, the long-term use of these drugs may 
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cause detrimental side effects. Another approach to reduce the plasma cholesterol 
level is to maintain bile acid homeostasis in the GI tract. Bile acids are part of the 
cholesterol metabolism pathway, so effective sequestration and removal of bile offers 
an alternative therapeutic approach to treat cardiovascular diseases.  
One type of bile acid sequestrant is cationically charged cross-linked polymeric 
gel that binds anionic bile acids in the GI tract to produce non-absorbable complexes. 
These polymeric complexes restrain bile acids from being systemically absorbed and 
are eliminated from the body through fecal excretion.  The common features of these 
polymers include the presence of amine/ ammonium groups in adequate densities 
along polymer chains and the presence of hydrophobic chains. A novel 
polyammonium salt containing hydrophobically modified hydrogel was introduced as 
a candidate for clinical development (Figure 1-5). The novel polymer has been 
approved as cholesterol lowering therapy under the generic name of colesevelam 
hydrochloride. It is being marketed under the trade name WelChol™ in the USA and 
Cholestagel® in Europe for the treatment of hypercholesterolemia. 
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Figure 1-5: Structure of a polymeric bile acid sequestrant.
22
 
 
1.2.3 Chelating Polymers as Iron Sequestering Agents 
 
Iron is an essential element in biological systems and it is needed for many critical 
human biological processes. Yet, the presence of excess iron in the body leads to 
toxic effects. The pathologic effects of iron accumulation in tissue are recognized
 
in 
diseases of systemic iron overload, in which the liver, heart,
 
and endocrine glands are 
the principal affected organs.
23 
At
 
the cellular level, labile iron begins to rise once the 
intracellular
 
capacity for iron storage is surpassed, leading to catalytic
 
formation of 
reactive oxygen species (ROS) that ultimately overwhelm
 
the cellular antioxidant 
defense mechanisms and lead to cell
 
damage. Under normal physiological conditions, 
iron metabolism is tightly conserved with the majority of the iron being recycled 
within the body. Unsequestered “free” iron can act as a bacterial virulence enhancing 
10 
 
factor.
19
 Normal physiology does not provide a mechanism for iron loss through the 
processes of excretion in urine, feces, or bile.  
“Iron overload disorders” refers to a class of diseases caused by the accumulation 
of iron in the body due to any cause.  The causes can be distinguished between 
primary/hereditary and, less frequently, secondary iron overload. Hemochromatosis is 
an inherited iron storage disease. It is usually due to mutations in the high Fe (HFE) 
gene. Secondary iron overload is acquired as a result of another disease. The main 
causes of secondary iron overload are haemolytic anaemias, β thalassaemia and 
chronic liver disease. Untreated hereditary hemochromatosis leads to severe iron 
overload, whereas in secondary iron overload (e.g. resulting from liver diseases) 
minimal to modest iron overload is usually observed. 
Current treatments for iron overload diseases center on chelation therapy. The 
principal goal of chelation therapy is to decrease tissue
 
iron to concentrations where 
iron-mediated toxicity cannot occur.
 
Only a small fraction of body iron is available 
for chelation
 
at any given time and the majority of stored iron is not effectively
 
chelated at clinically achievable chelator concentrations. Return to safe tissue iron 
levels therefore takes many
 
months or years with current chelation regimens.
24
 
Siderophores are relatively low molecular weight, ferric ion specific chelating 
agents elaborated by bacteria and fungi growing under low iron stress.
25
 The role of 
these compounds is to scavenge iron from the environment and to make the metal, 
which is almost always essential, available to the microorganism. Siderophores have 
been related to virulence mechanisms in microorganisms pathogenic to both animals 
11 
 
and plants.
25
 As naturally occurring chelating agents for iron, siderophores might be 
expected to be somewhat less harmful for deferrization of patients suffering from 
transfusion-induced siderosis. A siderophore from Streptomyces pilosus, 
desferrioxamine B, is marketed under the trade name Desferal
®
, and is advocated for 
removal of excess iron resulting from the supportive therapy for thalassaemia.  
Deferoxamine B (DFO), which is administered by subcutaneous infusion has 
shown clear advantages; however, concern has arisen over its use due to numerous, 
significant toxicities.
26
  Two other orally administered drugs, Deferiprone 
(Ferriprox
®
) and Deferasirox (Exjade
®
), are also known to have an effective impact in 
treatment of iron overload disorders (Figure 1-6). However, several studies have 
reported serious side effects following the administration of these drugs.
27
 These side 
effects have included bone dysplasia, auditory toxicity, hearing loss and ocular 
toxicity. Serious adverse events such as neutropenia, agranulocytosis, hypersensitivity 
reactions and blood vessel inflammation have also been reported upon the oral 
application of Deferiprone and Deferasirox (Table 1-1).
28
 Enterobactin is another 
high affinity siderophore that acquires iron for microbial systems. It is the strongest 
siderophore known, binding to the ferric ion (Fe
3+
) with an affinity of K = 10
52
 M
-1
. 
The objective of this thesis was to copy the high affinity, siderophore-mediated iron 
uptake system of bacteria by using polymers to mimic the structure of naturally 
occurring siderophores, i.e. enterobactin. 
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Figure 1-6: Structure of current iron chelators. 
 
 
Table 1-1: Properties of FDA-approved iron chelators.  
Deferoxamine; DFO Deferiprone; DFP Deferasirox; DFX
Chelator molecule: 
iron atom
Usual dose 25-50 mg/Kg 75-90 mg/Kg 10-30 mg/Kg
Administration Oral, twice daily-
three times daily
Oral, once daily
Subcutaneous, intravenous 
(8-12 hrs), 5 days per week
Side effects Local inflammatory 
reaction, visual and auditory
disturbances, disturbances 
of bone growth, alergic 
reactions, pulmonary, renal 
and neurological 
manifestations 
Gastrointestinal  
manifestation skin
exanthem, rise in 
serum creatinine level, 
visual and auditory 
disturbances 
Gastrointestinal 
manifestation,
agranulocytosis
/neutropenia, arthalagia
elevated liver enzymes
1:1 3:1 2:1
 
 
Non-absorbed polymeric ligands that selectively sequester and remove dietary 
iron from the GI tract appear to be attractive therapeutic agents for the treatment of 
13 
 
certain iron overload conditions. Restriction of these functional polymers to the GI 
tract or other areas of human body for elimination offers a unique medical benefit, 
when it is desirable to confine a therapeutic agent from systemic exposure. 
Furthermore, these polymers are capable of selectively recognizing and binding iron 
in intestinal fluids which makes them a new class of therapeutic agents that block 
absorption of these potentially detrimental species from the GI tract. Moreover, the 
ability to incorporate a variety of binding sites as well as high density of such groups 
along a polymer chain can lead to “polyvalent” interaction with target ligands 
yielding much higher binding constants than what one would observe with smaller 
molecular weight drugs.  
Crosslinked polymeric hydrogels containing hydroxamic acid and catechol 
moieties as well as crosslinked polymeric amines have been reported as iron 
chelators.
29-30
 Under in vitro conditions, all of these polymers sequester iron at pH 
values greater than 7.0. Evaluation of the iron chelating properties of these polymers 
suggests that they are comparable to current low molecular weight chelators and have 
potential application in iron overload therapy.  One goal of this dissertation was to 
introduce new polymeric hydrogels that exhibited higher affinity and selectivity 
toward Fe at relatively low pH when compared to existing polymers. 
1.2.4 Chelating Polymers as Toxic Metal Sequestrants 
Heavy metals can be substantial pollutants in source and treated water, and are 
becoming a severe public health problem. Heavy metal ions are reported as priority 
pollutants, due to their mobility in natural water ecosystems and due to their 
14 
 
toxicity.
31
 The presence of copper, zinc, cadmium, lead, mercury, iron, nickel and 
others metals, can have a damaging effect on human physiology and other biological 
systems when tolerance levels are exceeded. The heavy metal ions are stable and 
persistent environmental contaminants since they cannot be easily degraded and 
destroyed. Several methods exist to remove detrimental metal ions from aqueous 
solutions; however, heavy metal toxicity still remains an issue even for treated 
water.
32
  
Toxic effects of metals depend on nutritional status, age and gender, as well as the 
amount and route of exposure, tissue distribution, concentration achieved, and 
excretion rate. Mechanisms of toxicity include inhibition of enzyme activity and 
protein synthesis, alterations in nucleic acid function, and changes in cell membrane 
permeability.
33
 These detrimental effects are likely to have long-lasting consequences 
such as damaging the developing brain.
34
 
Chelating agents have been used as antidotes for metal intoxication in humans. 
One of the first applied chelators was British Anti-Lewisite (BAL).
35
 BAL was 
developed during the Second World War in England as an antidote for the arsenic- 
containing warfare agent lewisite. After the war, BAL was used as a chelating agent 
to sequester arsenic, gold, and mercury. Calcium disodium 
ethylenediaminetetraacetate (CaNa2EDTA), deferoxamine, and D-penicillamine were 
also introduced as metal chelators around the same time. Today, these drugs, together 
with a wide array of newly synthesized chelating agents, are in clinical use or under 
15 
 
preclinical or clinical investigations for treatment of intoxication or overload caused 
by various transition metals.
36
 
Lead is a ubiquitous metal that has been used by humans for more than three 
thousand years. It appears in the environment both from natural sources and released 
by human activities (industrial emission, car exhaust from leaded gasoline, burning 
coal or oil, and burning solid waste). The general population is exposed to lead 
mostly by lead-contaminated food or drinking water.
37
 Cigarette smoke also contains 
lead. Despite efforts to control lead exposure and despite apparent success in 
decreasing the incidence, serious cases of lead poisoning still appear in both 
developed and developing countries all over the world.
36
  
Lead perturbs multiple enzyme systems. As with most heavy metals, any ligand 
with sulfhydryl groups is vulnerable. The main targets for lead toxicity are the 
nervous system, especially in children, the hematopoietic system, sperm production, 
kidney, and possibly the blood pressure regulation system. BAL is an efficient 
chelator in acute intoxication with inorganic lead. This drug is commercially available 
but is known to be very toxic. Succimer, meso-2,3-dimercaptosuccinic acid (meso-
DMSA), 2,3- dimercaptopropane-1-sulphonic acid (DMPS), and D-penicillamine 
(DPA), are other options for the treatment which are orally active and less toxic 
compared to BAL.
38
  
Exposure to cadmium occurs mostly in the workplace from cadmium fumes and 
dust in industries where cadmium products are made. The general population is 
exposed from breathing cigarette smoke or eating cadmium-contaminated food 
16 
 
(cereal products, grains, sea food, potatoes, leafy vegetables).
36
 Cadmium can cause 
kidney disease; it damages the lungs, and may irritate the digestive tract. Long-term 
exposure to low levels of cadmium in air, food or water leads to an accumulation of 
cadmium in the kidneys and possible kidney disease. Improved regimens and choices 
of chelation therapy in cadmium-exposed individuals are needed. To date no efficient 
chelating treatment has been recommended for human usage.
36
  
Arsenic has a long history as a human poison. Arsenic is found in certain water 
supplies, seafood, glues, pigments, and cigarette smoke. Today, arsenic poisoning 
occurs through industrial exposure, from contaminated wine or illegally distilled 
alcohol beverages or because of malicious intent. Very few organ systems escape the 
toxic effects of arsenic. It is also listed as a confirmed human carcinogen, based on 
the increased prevalence of lung and skin cancer observed in human populations with 
chronic exposure, primarily through industrial inhalation.
39
 Chelation therapy is 
imperative in all symptomatic patients; however, the use of chelators in patients 
exposed to arsine gas is controversial.
36
 It was found that the most efficacious 
chelators in arsenic poisonings are meso-DMSA and DMPS, although less efficient 
chelators, BAL and DPA, are still in use.
36
 
1.3 Metal Chelating Polymers in Imaging 
Radio imaging (RI) and magnetic resonance imaging (MRI) are important tools in the 
non-invasive diagnosis of diseases. The main goal of developing contrast agents is to 
improve the contrast for target organs which eventually would lead to more sensitive 
and more accurate detection. Radio isotopes of iodine have been used in thyroid 
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metabolism studies and in in vitro radioimmunoassays.
40
 Iodine is not efficient for 
improving the contrast in MRI and none of the iodine isotopes have both ideal nuclear 
properties and availability for large scale use for in vivo diagnostics. 
Most widely used contrast agents for MRI were selected from transition metals 
and rare earth metals. Some of these are normally present in the body as trace 
elements (Mn, Fe, Cr) and are considered less toxic for this reason. Nevertheless, as 
pointed out earlier even trace elements may induce adverse toxic effects when the 
regulation of absorption is bypassed by parenteral administration. To reduce metal ion 
toxicity, the concepts of covalent binding, chelation, coupling to proteins or peptides, 
inclusion into dextrins, liposomes or cells, and weakly dissociated salts have been 
investigated.
41
 Formation of weakly dissociated salts, chelation and other methods are 
of general applicability and are widely used for the preparation of contrast agents 
based on metallic ions. The chelating method is of particular interest in that acute and 
long term toxicity of both the metal and the chelating agents are dramatically reduced 
owing to the complexation.  
To differentiate the area of interest from surrounding tissues, sufficient contrast 
enhancement must be achieved. Contrast agents aim to attenuate or enhance certain 
signal to a great extent than surrounding tissues, thus providing a clear contrast 
between healthy and diseased tissue. Nanoparticles have been fabricated and 
employed to further increase the local concentration of a contrast agent. This can 
improve delivery of contrast agents to areas of interest, thus enhancing signal from 
these areas
42
. In most cases, metals have been incorporated within the nanoparicles 
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through metal chelation. Liposomes and micelles have received attention over the 
past years because of their controllable properties and good pharmacological 
characteristics.  
Several approaches are used to incorporate the metal within these carriers. One 
approach is to chelate the reporter metal into a soluble chelate and then include it into 
the interior of a liposome. For some diagnostic applications, the administration of 
diagnostic particulates of a very small size (<50 nm) is required. Emerging needs for 
an increased liposome load with diagnostic moieties while decreasing the size of 
particles lead to the development of amphiphilic polychelating polymers (PAP). The 
main chain of the fabricated polymers included multiple side chelating groups 
capable of firmly binding many reporter metal atoms.
41
 In MR imaging, metal atoms 
chelated by polymer side groups are directly exposed to the water environment that 
enhances the relaxivity of the paramagnetic ions and leads to the corresponding 
enhancement of the vesicle contrast properties.  
Transition metals are often used as imaging probes. The low molecular weight 
metals, manganese and iron, are two of most common metals used as MRI probes. 
These metal ions contain unpaired electrons which facilitate T1 relaxation by 
interacting with water protons. Iron contrast agents can be prepared as small or large 
particles. The larger ones are ferromagnetic and contain multiple alignable magnetic 
domains, whereas the small particles of a few nanometers in diameter have a single 
alignable magnetic domain and are highly paramagnetic (superparamagnetic). Iron is 
a transition metal whose wholebody content is approximately three magnitudes higher 
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than that of manganese and its use as a contrast agent leads neither to a higher level of 
free iron ions nor to toxicity. The iron released from this contrast agent may become 
incorporated into the body’s iron store. Manganese is administered in complexed 
forms to diminish the toxicity of the free metal ions and to improve urinary 
elimination without significant loss of the paramagnetic properties. The normal 
manganese whole-body content in humans is 12–20 mg while the MRI doses are 
usually ranging from 15 to 45 mg of metal. 
Other elements from the first transition metal group such as copper, chromium or 
nickel can also be used as contrast agents.  Chromium has been used either as 
radioactive chromium for cell radiolabelling or in a non-radioactive form for killer 
lymphocyte labeling.
43
 Nicle–Diethylene triamine pentaacetic acid (Ni-DTPA) doped 
agarose gel is a phantom material for Gd–DTPA enhancement of contrast.
44
 
Nevertheless, this element has been used very little compared to manganese and iron.  
1.4 Conclusion 
Because of the unique properties of metal binding polymers, these materials are 
being utilized in a variety of biomedical applications. Biologically inspired metal 
chelating polymers have been used as sequestrating agents for bile acid and phosphate 
in patients with elevated cholesterol levels and chronic kidney disease, respectively. 
Similar polymers are also interesting candidates for use as an iron sequestrating agent 
in patients suffering from hemochromatosis. The overall goal of this work was to 
develop biologically inspired polymers capable of binding iron or toxic metals. Iron 
binding polymers can have application in treatment of hemochromatosis where 
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patients absorb excess iron from the GI tract. The selective and effective binding of 
iron by these polymers within the GI tract prevents the absorption of excess iron from 
the intestine.  
In this thesis, 2,3 dihydroxybenzoic acid was used to mimic the structure of 
enterobactin, a naturally occurring, high affinity siderophore that acquires iron for 
microbial systems. Further, the iron chelating properties of biomimetic polymer were 
improved to achieve optimized iron absorption within the GI tract. 
Polymers containing thioglycolic acid explored to mimic the structure of those 
enzymes that are functionally perturbed following poisoning with toxic metals. In 
most cases, a toxic metal replaces zinc, which already has been chelated by thiol 
groups within the enzyme. Biomimetic polymers offer potential applications for 
chelation therapy and detoxification.  
Finally, nanoparticles are of great interest as contrast agents in MR imaging. The 
last goal of this work was to develop a magnetic nanoparticle with enhanced 
magnetization. The chelating property of functional polymers was utilized to facilitate 
the magnetic property within polymeric network.  
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Siderophore-mimetic Hydrogel for Iron Chelation Therapy 
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2.1 Introduction 
Chelate-forming hydrogels have found widespread application in the selective 
extraction of trace heavy metal ions from aqueous solutions.
45-46
 More recently, 
studies have shown that hydrogels have been successfully used as non-absorbable 
drugs for sequestrating phosphate and cholesterol.
47
 Desirable chelating hydrogels 
have a higher selectivity than ion-exchange resins in sorption processes. Chemical 
modification of hydrogels is a well-established technique for the fabrication of 
selective chelate-forming polymers.
48-49
 Functional monomer(s) or grafted side 
groups may be introduced to the hydrogel to form covalent or non-covalently bonds.
50
 
The chelation characteristics of the modified hydrogel are largely dependent on the 
density and composition of the ligands incorporated into the polymeric matrix as well 
as the type of linker used for conjugation in the case of grafted polymer.   
Fe(III) chelators are currently desired because of the toxic effects of iron overload 
and the biological implications of excess iron in all living organisms.
51
 As a specific 
approach for the removal of Fe (III), immobilization of Fe (III) chelators onto 
Sepharose hydrogels has been investigated. This method was found to be useful in the 
treatment of Fe(III) overload and wastewater treatment.
52-53
 The Fe(III) chelating 
resins and polymeric Fe(III) chelating agents reported so far are based on 
immobilized desferrioxamine or hydroxamic acid polymers.
54-55
 Desferrioxamine 
(DFO), a naturally occurring Fe (III) chelator, has a strong affinity and selectivity for 
Fe (III). DFO is one of drugs approved by FDA in clinical use for the treatment of 
iron overload in patients
56
. 
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 Microorganisms have developed a sophisticated Fe (III) acquisition and transport 
systems involving siderophores. Siderophores are low molecular weight chelating 
agents that bind Fe (III) ion with high specificity. These potent and specific chelators 
usually include either catecholate or hydroxamate functional groups for iron 
coordination.
57
 Enterobactin, a naturally occurring tris-catechol siderophore, is the 
most powerful Fe(III) chelator known with an overall stability constant of 10
49
 
(Scheme 1). More recently researchers have been trying to mimic the structure of this 
siderophore to design iron chelators with relatively high affinity and selectivity 
toward iron. 
58-59
 
 Here, we report the synthesis and characterization of a highly effective iron 
chelator that mimics the enterobactin structure (Figure 2-7). Polyallylamine (PAAm) 
is a polycation hydrogel consisting of reactive primary amine side groups which can 
be conjugated to 2,3 dihydroxybenzoic acid (2,3 DHBA), the iron chelating domain 
of the enterobactin.
60-61 
 PAAm hydrogel was synthesized by cross-linking the 
precursor PAAm chains. Conjugation of 2,3 dihydroxybenzoic acid dramatically 
improved the iron binding affinity and iron selectivity of the final hydrogel. The 
selective and rapid, high affinity binding of iron by this siderophore-mimetic 
hydrogel offers potential for applications in iron chelation therapy in patients 
suffering from iron overload diseases.  
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Figure 2-7: A structural diagram of enterobactin with one arm of the ligand 
emphasized (A). Structure of the hydrogel synthesized in this study (B). 
 
2.2 Materials and Methods 
Material: Poly(allylamine hydrochloride) (PAAm) with an average molecular weight 
of 56 kDa and analytical grade reagent N,N’- methylenebisacrylamide (MBA) were 
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obtained from Sigma-Aldrich and used without further modification. 2,3 
dihydroxybenzoic acid, N,N,N-triethylamine, dimethylformamide (DMF), citric acid, 
potassium phosphate and all metal chlorides were purchased from Fisher Scientific 
and used as received. Dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide 
(NHS) were purchased from Thermo Scientific and used without further 
modification. Deionized water (DI) was obtained from a Barnstead EasyPure water 
purifier. 
Preparation of PAAm Hydrogel: PAAm was cross-linked with MBA by a Michael-
type addition reaction. This cross-linking procedure was developed by Oliveira et al. 
to synthesize PAAm and poly(α-L-lysine hydrobromide) hydrogels.
62
 Briefly, a 20% 
w/v polymer solution containing a predetermined amount of MBA was prepared. The 
cross-linker was dissolved in deionized water (flushed with nitrogen for 5 min) and 
then added to the polyallylamine polymer. Several different molar ratios of cross-
linking agent to PAAm were investigated. TEA, the cross-linking catalyst (300 μL), 
was then added to the solutions and mixed thoroughly. Next, the precursors were 
transferred by micropipet into small plastic cuvetts and subsequently covered with 
parafilm. The cuvettes were held at ambient temperature for 1 h and then cooled to 
ca. 3 °C and held there for an additional 24 h. After this time, hydrogels were 
removed from the cuvettes and washed with 0.05 M sodium chloride for several days. 
Multiple synthesis conditions were employed to prepare the hydrogel investigated in 
this study (Table 2-2). 
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Swelling studies: The swelling behavior of hydrogels was studied using buffered 
solutions with fixed ionic strength (0.5 M). An historic protocol by Elving et al. was 
used for making buffer solution with a known ionic strength.
63
 Dried samples with 
known weights (irregular dimensions) were placed in a solution of defined pH at 
room temperature. Samples were taken from the solution after reaching equilibrium. 
The swelling indexes (SI) were calculated using the following equation:  
                                          (1-2) 
 where Ws is the weight of the swollen hydrogel at an equilibrium state, and Wd is the 
weight of the dried hydrogel. 
2,3 Dihydroxybenzoic acid modification of hydrogel: A solution of 2,3 DHBA (100 
mg, 0.65 mmol) and NHS (74 mg, 0.65 mmol) in 5 mL of DMF was mixed with a 
solution of DCC (67 mg, 0.325 mmol) in 5 mL of DMF. The mixture was stirred at 
low temperature for 6 h to give a white precipitate. The precipitate was filtered, and 
the filtrate was added directly to a dry gel with known weight (25 mg). PAAm 
hydrogels were ground to ~0.5-1 mm particles. The reaction mixture was held at 
room temperature for 3 days. PAAm conjugate hydrogel was then washed with water 
for several days. 
Quantification of Amine Functional Group:  Primary amine groups were quantified 
by potentiometric titration. After grinding to a powder, 40 mg of PAAm and 
PAAm/DHBA polymer were suspended in 35 mL of 0.2 M aqueous KCl solution. 
Next, 140 μL of 8 M KOH aqueous solution was added to polymer suspensions to 
d
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W
WW
SI


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raise the pH to ~12. Standard 0.1 M HCl was used to titrate the suspension. HCl was 
added until the pH was about 2.5 in both polymer suspensions. Free amine groups 
were quantified from potentiometric data. 
Binding Kinetics Study: Ferric chloride solution (2 mg/mL) was adjusted to pH 6.5 
and kept at room temperature for kinetic studies. Samples were taken from the media 
at different time intervals to determine the rate of iron binding by PAAm/DHBA. 
Binding Experiments: Known concentrations of ferric chloride and ferrous chloride 
solutions (0.25, 0.5, 1, 2, and 2.5) mg/mL were prepared. Binding experiments were 
carried out by taking 20 mL of metal solutions in 125 mL volumetric flasks, solutions 
were adjusted to the desired pH while maintaining iron concentration. Next, a known 
mass of PAAm/DHBA particles with a size of about 0.5-1 mm was added to the 
mixture and was held at room temperature for 2 h or until equilibrium was reached. 
The solutions were then filtered and the filtrates were analyzed for metal 
concentration. 
Selectivity Study: The selectivity for Fe by PAAm/DHBA in the presence of several 
heavy metals such as copper, zinc, manganese, calcium, and potassium was studied. 
Metal solutions (10 mL) containing a 1:1 (wt) mixture of iron and heavy metals were 
prepared (2 mg/mL). The solution mixtures were then adjusted to pH 2.5, 4, 5, and 7 
and held at room temperature for 2 h after adding a known mass of PAAm/DHBA. 
Metal analysis: Mono- and multi-elemental analysis of samples was quantified by 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) (Optima 
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2000 DV, PerkinElmer, USA) fitted with an AS 93plus autosampler (PerkinElmer, 
USA). A Cross-Flow nebulizer and a Scott spray chamber were used. The RF Power 
was 1300 W and nebulizer and auxiliary flows were 0.8 and 0.2 L/min, respectively. 
Sample flow was set at 1.5 mL/min. ICP-OES data was processed using Winlab 32 
(Ver. 3.0, PerkinElmer, USA). The analytical curves used for samples analysis had 
coefficients of correlation >0.999. 
Adsorption isotherms: Different isotherm models were employed to determine how 
the metal molecules distributed between the liquid phase and the solid hydrogel phase 
when the adsorption process reached equilibrium state. Langmuir, Freundlich, and 
Temkin isotherm models were applied to the data. Adsorption parameters of ferric 
and ferrous ions were calculated at different pH values. The accuracy of the isotherm 
models was evaluated by linear correlation coefficient (R
2
 ) values.  
Langmuir isotherm: Langmuir isotherms assume monolayer adsorption onto a surface 
containing a finite number of adsorption sites. The linear form of the Langmuir 
isotherm equation is given as:  
maxmax
1
q
C
Kqq
C e
Le
e                                      (2-2) 
where Ce is the equilibrium concentration of the metal ion (mg/L), qe is the amount of 
metal ion adsorbed per unit mass of hydrogel (mg/g), KL and qmax are Langmuir 
constants related to the adsorption/desorption energy and adsorption capacity, 
respectively. When Ce/qe was plotted against Ce, a straight line with slope of 1/qmax 
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was obtained. The R
2
 values are summarized in Table 2.  The Langmuir constants KL 
and qmax were calculated from Eq. (2) and their values are shown in Table 2-3.  
Freundlich isotherm: Freundlich isotherms assume heterogeneous surface energies, in 
which the energy term in the Langmuir equation varies as a function of the surface 
coverage. The linear form of the Freundlich isotherm is given by the following 
equation: 
eFe C
n
Kq ln
1
lnln                                    (3-2) 
where Ce is the equilibrium concentration of the metal ion (mg/L), qe is the amount of 
metal ion adsorbed per unit mass of hydrogel (mg/g), KF (mg/g (l/mg)1/n) and n are 
Freundlich constants with n giving an indication of how favorable the absorption 
process is. The plot of lnqe versus lnCe gave a straight line with slope of 1/n.  
Freundlich constants KF and n were also calculated and are listed in Table 2-3. 
Temkin isotherm: Temkin and Pyzhev considered the effects of indirect adsorbate/ 
adsorbent interactions on adsorption isotherms.
64
 The heat of adsorption of all the 
molecules in the layer would decrease linearly with coverage due to 
adsorbate/adsorbent interactions. The Temkin isotherm has been used in the form as 
follows: 
)ln( ee AC
b
RT
q 





                                      (4-2) 
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A plot of qe versus lnCe yielded a straight line. The constants A and b together with 
the R
2
 values are shown in Table 2-3. 
2.3 Results and Discussions 
Synthesis and characterization: Poly(allylamine hydrochloride) was cross-linked with 
N,N-methylenebisacrylamide (MBA) by a Michael-type addition reaction.
65
 The 
reaction was performed in water using several monomers to cross-linker ratios. An 
acceptable hydrogel yield was obtained for various reaction conditions (Table 2-2).  
Table 2-2: Reaction conditions and swelling behavior of hydrogel at pH=6. 
PAAm (mg) Cross-linker (mg) A/B* Swelling index** Yield (%)
123.6 21.2 0.1 8.0 79.6
124.3 33.9 0.2 7.1 75.7
126.4 45.8 0.3 5.0 76.8
124.9 58.9 0.4 4.6 68.0  
* mole ratio of crosslinker double bonds to polymer amines. 
** swelling index of PAAm/DHBA hydrogel. 
 
Although cross-linking was done by linking the primary amine groups, there were 
still a considerable number of reactive amino sites available for further modification 
of the PAAm hydrogel. 2,3 DHBA was covalently linked to the PAAm hydrogel via 
DCC/NHC conjugation chemistry.  
Swelling studies: The swelling kinetics of PAAm and PAAm/DHBA were studied to 
determine the time to reach equilibrium. Hydrogel swelling increased with time; 
however, it eventually plateaued, thus, allowing calculation of the equilibrium 
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swelling percentage. PAAm hydrogel reached equilibrium in 10 h whereas 
PAAm/DBHA reached equilibrium in less than 1 hr (Figure 2-8).  
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Figure 2-8: Kinetic swelling data for PAAm (A) and PAAm/DHBA (B) hydrogels at 
pH=6, PAAm:DHBA= 5.68. 
 
The cross-linker concentration was varied and the swelling behavior of the final 
PAAm hydrogels was determined. Table 2-2 includes swelling indexes of PAAm 
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hydrogels with different PAAm: cross-linker ratios. A 2.7 ratio was selected because 
the swelling index for this ratio is within an acceptable range for either chemical or 
biomedical applications.
66
  Next, The swelling behaviors of the hydrogels  
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Figure 2-9: Swelling index of PAAm hydrogels with different cross-linker: polymer 
ratios at different pH values (A), swelling index of PAAm/DHBA with a 2.7 cross-
linker: polymer at different pH values (B) (ionic strength=0.5 M). 
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were further investigated as a function of pH by immersing the gels in buffered 
solutions at pH 1, 2, 4, 5, and 7.4 at room temperature (~25°C).  
The swelling behavior of PAAm was determined after equilibrating at different 
pH values (Figure 2-9).  The swelling of the PAAm hydrogel is higher at low pH 
values, with the maximum swelling observed at a pH of 2.2. This could be attributed 
to the complete protonation of the amine groups of PAAm at low pH. The pKa of 
primary amines in PAAm is ~ 9.67; therefore, the behavior observed resulted from 
the ionized amines of the polymer as expected.
67
 Osmotic pressure results from 
counterions to the protonated primary amines and is a probable cause of swelling. 
When immersed in electrolyte solutions, ion exchange takes place in these types of 
hydrogels  during the swelling process and can exert a considerable effect on the 
water absorption.
68
 The same experiment was carried out for PAAm conjugate 
hydrogels and the swelling behavior of the 2,3 DHBA modified gels was studied at 
different pH values (Figure 2-9). Because many of the amine groups were occupied 
via amide linkage, the ionizable groups within the hydrogel were diminished. Almost 
no significant changes in the swelling behavior were observed for PAAm/DHBA at 
different pH values.  Images of equal weights of the different hydrogels also 
illustrated the vast difference in swelling. PAAm hydrogels showed a significant 
reduction in swelling after modification by 2,3 DHBA (Figure 2-10). The occupation 
of ionizable amine groups after conjugation of DHBA greatly reduced water uptake 
and presumably reduced the uptake of counterions. 
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Figure 2-10: PAAm equilibrated in DI water (A), PAAm equilibrated in 2 mg/mL 
ferric solution (B), PAA/DHBA equilibrated in DI water (C) and PAAm/DHBA 
equilibrated in 2 mg/mL ferric solution (D). All hydrogels had equal masses.  
 
Moreover, PAAm/DHBA hydrogel further collapsed after immersion in a 2 
mg/mL solution of ferric chloride (Figure 2-10). Hydroxyl groups along with oxygen 
molecules bearing a negative charge (due to the partial double bond characteristic of 
the amide linkage) provided probable coordination sites for Fe. Moreover, as evident 
from potentiometric data, some protonated amine groups may also contribute to the 
coordination of Fe. The potentiometric data obtained for PAAm and PAAm/DHBA 
indicated that Ca. 23% of amine groups were occupied after conjugation reaction. 
Further collapse of PAAm/DHBA hydrogel in the ferric solution may be explained by 
multiple DHBA coordination of Fe.    
Binding Kinetics: Determination of the kinetics of metal absorption is critical in 
elucidating the reactivity of PAAm/DHBA and evaluating its potential for chemical 
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and biomedical applications. The kinetics of metal binding was monitored using a 
known initial concentration of metal solution (2 mg/mL, FeCl3) in the presence of a 
known mass of dry hydrogels. The equilibrium binding was found to be 1180 and 810 
mg Fe/g Gel for PAAm/DHBA and PAAm, respectively (Figure 2-11). 
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Figure 2-11: Ion binding by PAAm/DHBA hydrogels. Gels were equilibrated in 2 
mg/mL ferric solution (pH= 2, ionic strength=0.5 M). 
 
 About 80% of the total iron absorption was attained in less than 5 min for the 
PAAm/DHBA hydrogel. This rapid absorption behavior is important in biomedical 
application especially for treatment of acute metal poisoning. To derive the rate 
constant and binding capacity, the kinetic data were modeled with pseudo-first-order 
(Lagergren model) and pseudo-second-order (Ho model) kinetic models which are 
expressed in their linear forms as: 
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where k1 (L/min) and k2 (g/mg · min) are pseudo-first-order and pseudo-second-order 
rate constants, respectively. Fitted kinetic models are shown (Figure 2-12), and the 
model variables obtained by linear regression were compared (Table 2-3). The 
pseudo-second order reaction model showed the best fit for ferric ions because its R
2
 
was ~1.  
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Figure 2-12: Kinetic models fitted for PAAm/DHBA hydrogel. Gel was equilibrated 
in 2 mg/mL ferric solution (pH= 2, ionic strength=0.5 M). 
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Table 2-3: Kinetic parameters for ferric binding by PAAm/DHBA at pH=2. 
Kinetic model Rate constant Ion R
2
Pseudo-first order 0.24 ferric 0.9988
Pseudo-second order 0.23 ferric 1
 
 
Binding Isotherms: The metal ion binding capacity was determined at different pH 
values and different isotherm models were used to fit the data. At low pH, the metal 
ion uptake was relatively high. This could be due to the presence of protonated 
primary amine groups along with iron coordination sites, which together may 
improve the binding capacity of the hydrogel for iron. Increasing the pH decreased 
the ionization of the remaining primary amine groups, and in turn lower values for the 
metal ion uptake were observed. 
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Table 2-4: Isotherm parameters for ferric and ferrous binding by PAAm/DHBA. Gels 
were equilibrated in 2 mg/mL iron solutions. 
pH 2.2 5.4 7.4 2.2 5.4 7.4
Isotherm model
Freundlich
KF 77.53*10
+1
34.55*10
+2
31.33*10
+2
22.29*10
+2
43.84*10
+2
n 3.680 1.510 2.770 1.580 2.150
R
2
0.9884 0.9902 0.9927 0.9233 0.9895
sen 1.826*10
-2
3.289*10
-2
1.545*10
-2
9.546*10
-2
2.395*10
-2
sey 1.610*10
-2
2.821*10
-2
1.504*10
-2
2.928*10
-2
2.573*10
-2
Langmuir
qmax 52.63*10
+1
14.28*10
+2
20.00*10
+2
25.00*10
+2
14.28*10
+2
KL 63.33 17.50 25.00 2.000 87.50
R
2
0.9998 0.9823 0.9581 0.8216 0.9840
sen 3.100*10
-7
4.431*10
-6
1.901*10
-6
2.135*10
-5
5.699*10
-7
sey 1.126*10
-5
1.713*10
-4
6.645*10
-5
6.150*10
-5
1.253*10-4
Temkin
A 331.70 1.000 199.3 19.20 635.7
b 21.06 6.190 5.130 4.080 7.770
R
2
0.9637 0.9646 0.9639 0.9380 0.9612
sen 4.691 37.78 4.669*10
-2
7.805*10
-2
3.054*10
-2
sey 9.522 74.62 0.1046 5.512*10
-2
7.556*10
-2
Ferric Ferrous
 
 
The respective isotherm curves of ferric and ferrous solutions were obtained at 
different pH values (Figure 2-13&Figure 2-14).  
 Modeling of isotherm data is vital for deriving meaningful information of binding 
characteristics, such as maximum binding capacity and binding constant. Therefore, 
several theoretical isotherm equations, including those of Freundlich, Langmuir, and 
Temkin, were employed to evaluate which could best describe the experimental data. 
Generally, the Freundlich and Temkin models are applicable to heterogeneous 
systems, while the Langmuir model is based on a homogeneous monolayer 
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adsorption. Among the three models, both Freundlich and Temkin models provided 
accurate ferric and ferrous isotherms at low implying the heterogeneous nature of 
adsorption (Figure 2-13& Figure 2-14). 
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Figure 2-13: Binding isotherms for ferric ions at pH 2-3 (A) and 5-6 (B) 
  
R
2
 values obtained for these models were close to unity compared to the 
Langmuir model (Table 2-4). The data may allow speculation that more than one type 
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of binding site with different affinities may be involved in iron binding by 
PAAm/DHBA. This hypothesis will require further studies to confirm or refute.  
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Figure 2-14: Binding isotherms for ferrous ions at pH 2-3 (A), 5-6 (B), and 7.4 (C). 
 
Ment et al. reported the removal of iron from different systems using Sepharose-
desferrioxamine B gels.
50
 They also studied the effect of the immobilization of other 
iron chelators like l-(fl-aminoethyl)-3- hydroxy-2-methyl-4-pyridinone (HP) and L-
mimosine onto Sepharose.
69
 However, the effectiveness of the immobilized DFO was 
low. Even though gels had a high affinity for Fe(III) and were used for removing iron 
from milk, wine, whey and lactoferrin, they were not very stable mainly due to 
hydrolysis of their isourea bonds.
50, 69
 In another study, Polomoscanik et al. studied 
the iron binding parameters of hydroxamic acid-containing hydrogels derived from 
derived from cross-linked polymeric acid chloride precursor and polymeric 
hydroxyethyl ester precursor. The maximum iron(III) binding capacities of these 
hydrogels were 0.81 and 0.45 mmol/g respectively.
70
 The maximum iron (III) binding 
capacity of PAAm/DHBA hydrogel varies between 9.3-25.5 mmol/g depending on 
the pH of the solution. 
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Selectivity Studies Effect of Essential Metal: One of the important features of metal 
chelating hydrogels is their ability to specifically target the metal of interest and 
remove it from the media. Selectivity is especially important if the desired application 
of the hydrogel is in the treatment of metal poisoning. The hydrogel selectivity may 
affect the bioavailability of some other essential metal ions such as Cu
2+
, Zn
2+
, Ca
2+
, 
Mn
2+
, Ni
2+
, or K
+
. Selective absorption of essential metals could cause serious 
damage to vital organs. The influence of essential metals on the binding of ferric ions 
was investigated using a multi-solute system to evaluate the metal selectivity of 
PAAm/DHBA at different pH values. At an equal concentration of all metals (2 
mg/mL), PAAm/DHBA absorbed almost 80% of the iron present in the media while 
typically the absorption for essential metals (e.g. Ca, Zn) was less than 50% (Figure 
2-15).  
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Figure 2-15: Selectivity study for PAAm/DHBA and PAAm hydrogels toward ferric 
ion in the presence of Mn
2+
, Cu
2+
, Ni
2+
, K+, and Ca
2+
 at different pH ranges. A: 
pH=2.5, B: pH=4, C: pH=5 and D: pH=7. 
 
The ratio was similar across a wide range of pH values. Zhou et al. has studied the 
selectivity of 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers 
(DMAA) for iron in the presence of some essential metals. Even though the DMAA 
hydrogel showed high affinity for iron it still bound Cu
2+
 efficiently (more than 53%). 
Comparatively, PAAm/DHBA showed a higher selectivity toward Fe in the presence 
of other metals, implying the greater stability of the Fe-PAAm/DHBA complex.  
2.4 Conclusions  
2,3 dihydroxybenzoic acid was immobilized on polyallylamine hydrogel to mimic the 
structure of the enterobactin, a potent, naturally occurring Fe (III) chelator. The final 
hydrogel was able to remove and accumulate ferric and ferrous ions from aqueous 
solutions at relatively low concentrations. PAAm/DHBA demonstrated an almost 
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instant iron absorbance when equilibrated in ferric solution. The pseudo-second order 
Ho kinetic model was found to be an excellent fit with the experimental results. These 
siderophore-mimetic hydrogels also exhibited a high affinity and selectivity for iron 
at different pH values. Freundlich and Temkin adsorption models adequately 
described the relationship between metal concentration in solution and the amount 
retained by the hydrogel. The high affinity and selectivity of PAAm/DHBA hydrogel 
for iron provides important features for this hydrogel in biomedical and chemical 
applications.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 Enhancing the Selectivity of an Iron Binding Hydrogel 
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3.1 Introduction 
Iron is an essential and ubiquitous element in all forms of life involved in a multitude 
of biological processes and essential for many critical human biological processes.
71-
73
 Yet, the presence of excess iron in the body leads to toxic effects.
74
 Iron is absorbed 
from the mammalian gastrointestinal tract by protein-mediated mechanisms.
75
 Body 
iron levels are tightly controlled by the absorption process. Excess iron is extremely 
toxic due to its ability to generate relatively high levels of the hydroxyl radical.
76
 
Moreover, un-sequestered iron can also act as a bacterial virulence enhancing 
factor.
71
 Under normal physiological conditions, iron metabolism is tightly conserved 
with the majority of the iron being recycled within the body.
77
 Normal physiology 
does not provide a mechanism for iron excretion in urine, feces, or bile.
78
 Certain 
genetic disorders like hemochromatosis can lead to an increased systemic absorption 
of dietary iron.
79
 Iron overload also results from blood transfusions in the case of β-
thalassaemia and sickle cell anemia patients.
80
 
The current standard of care for iron overload diseases is iron chelation therapy 
with desferrioxamine.
73
 Desferrioxamine (DFO) therapy has reportedly been 
associated with several drawbacks including a narrow therapeutic window and lack of 
oral bioavailability.
70
 As a result, it requires administration for 8–12 h per day by 
infusion.
71
 DFO cannot be readily absorbed through the intestine and must be injected 
intravenously thus, is not an ideal chelator since systemic side effects are inevitable.
81
 
One possible method of avoiding the use of systemic iron chelators is to inhibit iron 
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absorption from the gastrointestinal tract by orally available, non-absorbed iron 
chelators that selectively sequester and remove excess dietary iron from the GI tract. 
Non-absorbed polymer therapeutics that act by sequestering a number of undesired 
ionic species in the gastrointestinal tract have been successful clinically.
77, 82-83
 This 
method is particularly relevant to thalassaemia intermedia and hemochromatosis. Iron 
binding polymers have considerable potential in this therapeutic approach as they can 
effectively bind iron irreversibly to form nontoxic, inert complexes that are not 
absorbed by the gastrointestinal tract, thereby reducing the absorption of iron from 
the intestine.  
Because of the importance of other metal ions for normal human physiology, 
clinically acceptable polymeric ligands must possess high affinity, capacity, and 
selectivity towards iron. Furthermore, such polymers should be biocompatible and 
preferably non-absorbed. These considerations prompted further improvement of the 
binding affinity and selectivity of previously reported siderophore-mimetic iron 
chelators. Polyallylamine (PAAm) hydrogels with conjugated 2,3 dihydroxybenzoic 
acid (2,3 DHBA) have been introduced as potential iron-specific chelating agents. 
Here the effect of the PAAm:DHBA ratio on the binding constant and the selectivity 
of the hydrogel was investigated. Several concentrations of DHBA were grafted 
within the gel and the stability constant of each corresponding concentration was 
calculated.  PAAm-DHBA hydrogel with ~ %15 grated DHBA with the gel network 
seemed to have an optimum affinity (Log K= 27.01), selectivity (its selectivity toward 
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Fe is ~ 3-14 times more than its selectivity toward other competing metals) and 
binding capacity (~600  mg/g dry gel) for Fe(III). 
3.2 Materials and Methods 
Material: Poly(allylamine hydrochloride) (PAAm) with an average molecular weight 
of 56 kDa and analytical grade reagent N,N’- methylenebisacrylamide (MBA) were 
obtained from Sigma-Aldrich and used without further modification. 2,3 
dihydroxybenzoic acid, N,N,N-triethylamine (TEA), dimethylformamide (DMF), and 
all metal chlorides were purchased from Fisher Scientific and used as received. 
Dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide (NHS) were purchased 
from Thermo Scientific and used without further modification. Deionized water (DI) 
was obtained from a Barnstead EasyPure water purifier. 
Preparation of PAAm Hydrogel: PAAm hydrogel was synthesized following the 
procedure reported in the literature.
84
 Briefly, a 20% w/v polymer solution containing 
a predetermined amount of MBA was prepared. The cross-linker was dissolved in 
deionized water (flushed with nitrogen for 5 min) and then added to the 
polyallylamine polymer. TEA, the cross-linking catalyst (300 μL), was then added to 
the solutions and mixed thoroughly. Next, the precursors were transferred by 
micropipet into a small plastic cuvette and subsequently covered with parafilm. The 
cuvettes were held at ambient temperature for 1 h and then cooled to ca. 3 °C and 
held there for an additional 24 h. After this time, hydrogels were removed from the 
cuvettes and washed with 0.05 M sodium chloride for several days.  
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2,3 Dihydroxybenzoic acid Modification of Hydrogel: A solution of 2,3 DHBA and 
NHS in 5 mL of DMF was mixed with a solution of DCC in 5 mL of DMF. The 
mixture was stirred at low temperature for 6 h to give a white precipitate. The 
precipitate was filtered, and the filtrate was added directly to dry gel particles with 
approximate size of about 0.5-1 mm. several concentrations of DHBA were grafted to 
the hydrogel network to optimize the selectivity and iron binding affinity of the final 
hydrogel (Table 1). The reaction mixture was held at room temperature for 3 days. 
PAAm conjugate hydrogel was then washed with water for several days. 
Quantification of Amine Functional Groups:  Primary amine groups were 
quantified by potentiometric titration. After grinding to a powder, 40 mg of PAAm 
and each PAAm-DHBA hydrogel were suspended in 35 mL of 0.2 M aqueous KCl 
solution. Next, 140 μL of 8 M KOH aqueous solution was added to polymer 
suspensions to raise the pH to ~12. Standard 0.1 M HCl was used to titrate the 
suspension. HCl was added until the pH was about 2.5 in both polymer suspensions. 
Free amine groups were quantified from potentiometric data following reported 
procedures.
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Polymer-Iron Stability Constant Determination: The stability constant of gel 
chelators was measured using an historic ligand competition assay.
86
 The competitive 
chelation of iron by polymeric chelator in equilibrium with a water-soluble chelator 
(ethylenediaminetetraacetic acid: EDTA) was used to determine the stability constant 
of iron-ligand complexes of PLL/DHBA hydrogel.  Briefly, to a 1.5 ml of 10 mM 
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EDTA solution was added 2 mL of 5 mM of FeCl3 solution and 21.5 mL PBS and a 
known mass of ground gel.  The mixture rotated at 20 °C for 3 days and the 
concentration of the soluble iron complex was determined by inductively coupled 
plasma mass spectroscopy (ICP-MS).  The stability constant of the gel was 
determined following the procedure reported in literature.
86
 The same procedure was 
repeated for all the different PAAm:DHBA ratios.    
Selectivity Study: The selectivity for Fe by PAAm-DHBA in the presence of several 
heavy metals such as copper, zinc, manganese, calcium, and potassium was studied. 
Metal solution (10 mL) containing all metal components was prepared. The upper 
tolerable intake level of each metal was used as an initial concentration in the 
solution. These concentrations were chosen on the basis of the U.S. recommended 
daily allowance (RDA) data on the daily dietary uptake of these metal ions present in 
a normal meal. The solution mixture was then adjusted to pH 2.5 and held at room 
temperature for 2 h after adding a known mass of PAAm-DHBA ground gel.  The 
selectivity study was carried out for all different PAAm-DHBA ratios. 
Metal Analysis: Mono- and multi-elemental analysis of samples was quantified by 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) (Optima 
2000 DV, PerkinElmer, USA) fitted with an AS 93plus autosampler (PerkinElmer, 
USA). A Cross-Flow nebulizer and a Scott spray chamber were used. The RF Power 
was 1300 W and nebulizer and auxiliary flows were 0.8 and 0.2 L/min, respectively. 
Sample flow was set at 1.5 mL/min. ICP-OES data was processed using Winlab 32 
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(Ver. 3.0, PerkinElmer, USA). The analytical curves used for sample analysis had 
coefficients of correlation >0.999. 
3.3. Results and Discussions 
Poly(allylamine hydrochloride) was cross-linked with N,N-
methylenebisacrylamide (MBA) by a Michael-type addition reaction. The ratio of 
monomer to cross-linker was selected based on recommendations from the 
literature.
87
 The DCC/NHS coupling chemistry was adopted to react the free amine 
side chains of the hydrogel with the carboxylic end of the 2,3 DHBA. Since the 
concentration of 2,3 DHBA hydroxyl groups is critical for enhanced binding of iron, 
the choice of appropriate PAAm:DHBA ratio was important for obtaining hydrogels 
with high iron affinity. To optimize the binding affinity and selectivity of the final 
product, several ratios of PAAm:DHBA were investigated (Table 3-5). 
Potentiometric titration data were used to calculate the degree of conjugation. The 
conjugation efficiency varied from 75%-95% depending on the initial concentration 
of 2,3 DHBA.  
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Table 3-5: Reaction conditions, conjugation reaction efficiency and conditional 
stability constants (Log k) of hydrogels. 
%DHBA grafted % conjugation Log K
86.10 95.71 27.04±0.06
14.97 73.95 27.01±0.24
8.45 83.00 26.6±0.42
1.41 69.50 26.4±0.28
0.00 0.00 25.2±0.28
 
Conditional Stability Constant of Fe(III)-Hydrogel: The ligand competition method is 
widely used for the determination of stability constants of both soluble iron(III)-
ligand complexes and cross-linked polymeric chelators.
86, 88
 The stability constants 
(log K) of PAAm-DHBA-iron complexes were considerably higher (×10) than of 
those similarly synthesized hydrogels (Table 3-5).
88
 A decrease in the concentration 
of DHBA resulted in a decrease of the conditional stability constant. As the 
concentration of functional groups incorporated in hydrogels decreased, the binding 
capacity of the hydrogel decreased as well (Figure 3-16& Figure 3-17). Chelating 
properties of a polymeric chelator have also been shown to be affected by steric 
hindrance between the ligand and the polymeric matrix, but in the case of PAAm-
DHBA hydrogels there may be little inference by the polymer backbone in the iron 
chelation process based on the binding capacities observed.
89-90
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A B
 
Figure 3-16: A: PAAm equilibrated in DI water, B: PAAm equilibrated in 2 mg/mL 
FeCl3 solution C: PAAm-DHBA (~0.3 Molar ratio) equilibrated in 2 mg/mL FeCl3 
solution, D: PAAm-DHBA (0.01 Molar ratio) equilibrated in 2 mg/mL FeCl3 
solution. All samples are single pieces and have equal masses, pH~2). 
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Figure 3-17: Kinetic studies of PAAm-DHBA hydrogels. Gels were equilibrated in 2 
mg/mL ferric solution (pH= 2, ionic strength=0.5 M). 
 
Zhou et al. have reported the synthesis of a range of iron binding dendrimers 
terminated with hexadentate ligands formed from hydroxypyridinone, 
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hydroxypyranone, and catechol moieties.
91
 The stability constant of these dendrimers 
were similar to those reported in this study. In another study, a series of polymeric 
iron chelators have been introduced by the synthesis of 3-hydroxypyridin-4-1 
hexadentate ligand incorporated into polymers via co-polymerization with N,N 
dimethylacrylamide, and N,N′-ethylene-bis-acrylamide. The Fe(III) chelation capacity 
of this polymer reached 80% within 1 h, and the stability constant (log K′) for 
iron(III) was determined to be 26.55, slightly lower than reported here.
88
   
Selectivity of the PAAm-DHBA hydrogels:  Since PAAm-DHBA hydrogels 
possessed a high affinity for Fe (III), it was anticipated that these hydrogels may also 
possess an improved selectivity for Fe (III) over other metal ions. Copper (II), zinc 
(II), and manganese (II) are all present in biological tissues and in food. As these 
three metals are essential for life, it is important that the hydrogels designed in this 
study possess much lower affinities for this group of divalent cations. In competition 
studies, iron(III) was shown to be selectively bound to the hydrogels in the presence 
of competing metals, i.e. Zn
2+
,Mn
2+
, and Cu
2+ 
(Table 3-6). In all these cases, iron 
concentrations were decreased significantly after incubation with hydrogel, whereas 
the concentrations of the competing bivalent metals remained almost unchanged.  
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Table 3-6: Selectivity of PAAm-DHBA hydrogel with different PAAm:DHBA molar 
ratio, pH~2. 
Fe absorbed/ competing metal
%DHBA 
grafted Fe/Zn Fe/Mn Fe/Cu
86.10 3.03 2.70 N/A
14.97 18.63 15.56 10.90
8.54 5.95 3.16 0.92
1.41 1.49 2.96 2.14
0 1.43 1.10 1.42
 
In comparison, Zhou et al. have reported a Fe(III) hydrogel chelator composed of 
a relatively high stability constant; however, the selectivity studies revealed that the 
binding capacity for both Fe(III) and Cu(II) were almost identical, indicating the lack 
of selectivity toward Fe(III).
88
  
3.4 Conclusion 
A cross-linked polymer that mimics the structure of enterobactin, a naturally 
occurring siderophore, was synthesized. 2,3 Dihydroxybenzoic acid, a metal binding 
domain of enterobactin, was used as a conjugated moiety to simulate the high iron 
affinity and selectivity of enterobactin. Several ratios of PAAm:DHBA were used to 
optimize the stability constant, selectivity and binding capacity of these iron chelating 
hydrogels. Hydrogels with ~ 15% DHBA grafted demonstrated high stability constant 
while maintaining selectivity and a high binding capacity for Fe (III). The high 
affinity and selectivity of PAAm-DHBA hydrogel for iron provides important 
features for this hydrogel in the treatment of iron overload disease such as 
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hemochromatosis. When administerded orally, these siderophoric-mimetic hydrogels 
may effectively absorb iron from the GI tract for excretion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
 
PLL/DHBA: A Potential Alternative for DFO  
Chelation Therapy 
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4.1 Introduction 
Under normal physiological conditions, iron metabolism and bioavailability are 
tightly controlled through dietary absorption, trafficking, and recycling of iron within 
the body. The human body does not have an active mechanism for iron excretion and 
therefore excess iron is usually stored in the body. Free iron is primarily stored in the 
liver, spleen, and bone marrow in the form of bound ferritin molecules. Several 
studies have been done on patients suffering from iron overload diseases. The results 
of these studies have demonstrated that an excess accumulation of free iron in the 
body occurs as a consequence of enhanced dietary uptake (hemochromatosis), 
medical treatment (chronic blood transfusions), destabilized hemoglobin (sickle cell 
disease), reduced hemoglobin (β thalassemia), or as a result of conditions such as 
cardiomyopathies, hepatic fibrosis and diabetes mellitus.
92
 To treat iron overload 
conditions such as these, iron chelation therapy is often employed.
93
 
The naturally occurring siderophore, deferoxamine (DFO), is one of the most 
effective chelators that has been approved for therapeutic use to remove the excessive 
accumulation of tissue iron.
94
 Although DFO may be clinically effective, it is beset by 
many disadvantages, the most significant of which are the high toxicity and very short 
plasma half-life (~5.5 min).
95
 Moreover, administration occurs via subcutaneous 
infusion over a long period of time.  This poses some difficulties with compliance as 
well as the high cost of patient care.
96
 In addition, DFO has serious side effects that 
require limiting the daily dose to a tolerable amount. Side effects include but are not 
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limited to local inflammatory reactions, visual and auditory disturbance, disturbances 
of bone growth, allergic reactions, and pulmonary, renal and neurological 
manifestations.
96
 Therefore, there is an urgent need for iron chelators that have fewer 
side effects while exhibiting excellent iron chelating efficacy.  
For the development of such molecules, attempts have been made to correlate the 
chemical structure as well as certain physical parameters with their biological 
activity. Controlled polymerization methods such as reversible addition fragment 
chain transfer and atom transfer radical polymerization developed over the last 
decade afforded the synthesis of polymer conjugates with predetermined molecular 
weight, composition, stability, and immunological and pharmacological properties.
97
 
One of the important features of an alternative chelator is that the resulting iron 
complex formed should be non-toxic and the coordinated iron should be protected 
from interaction with either hydrogen peroxide or oxygen. Here, the in vitro 
evaluation of siderophore-mimetic polymer, poly-L-lysine (PLL) conjugated to 2,3 
dihydroxybenzoic (2,3 DHBA) acid is reported as a new iron chelator. The rapid, 
selective absorption of iron and non-cytotoxic behavior of this compound make it 
suitable for iron chelation therapy. Moreover, the ability to predetermine the 
molecular weight of the polymer offers the potential to extend the plasma half-life of 
the chelator. 
58 
 
4.2 Materials and Methods 
Materials: Poly-L-lysine hydrobromide (PLL) with an average molecular weight of 
15-30 kDa was obtained from Sigma-Aldrich and used without further modification. 
2,3 dihydroxybenzoic acid (2,3 DHBA), N,N,N-triethylamine (TEA), 
dimethylformamide (DMF), potassium phosphate and all metal chlorides were 
purchased from Fisher Scientific and used as received. Dicyclohexylcarbodiimide 
(DCC) and N-hydroxysuccinimide (NHS) were purchased from Thermo Scientific 
and used without further modification. Deionized water (DI) was obtained from a 
Barnstead EasyPure water purifier. 
Blood: Blood plasma was collected from a male Wistar Rat (566 grams) following an 
IACUC-approved procedure. 
2,3 Dihydroxybenzoic acid modification of polymer: A solution of 2,3 DHBA (64 mg, 
0.42 mmol) and NHS (47.48 mg, 0.4 mmol) in 5 mL of DMF was mixed with a 
solution of DCC (42.5 mg, 0.2 mmol) in 5 mL of DMF. The mixture was stirred at 
room temperature (~ 23 
◦
C) for 6 hr to yield a white precipitate. The precipitate was 
filtered, and the filtrate was added directly to a solution of PLL (15mg/mL, 2 mL). 
The reaction mixture was held at room temperature for 6 hr. Next, DMF was 
evaporated using a rotovap and sample was kept in a vacuum oven overnight to 
ensure the complete evaporation of DMF. The PLL conjugate polymer product was 
dissolved in water and was dialyzed against water for several days. 
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Binding Kinetics Study: Ferric chloride solution (2 mg/mL) was adjusted to pH 6.5 
and kept at room temperature for kinetic studies.  The polymer solution was kept 
within a dialysis bag while immersed in a media containing FeCl3 solution. Iron 
concentration was read both from retentate and dialysate. Samples were taken from 
the media at different time intervals to determine the rate of iron binding by 
PLL/DHBA. 
Selectivity Study: The selectivity for Fe by PLL/DHBA in the presence of several 
heavy metals such as copper, zinc, manganese, calcium, and potassium was studied. 
Metal solutions (10 mL) containing a 1:1 (wt) mixture of iron and heavy metals were 
prepared (2 mg/mL). The solution mixtures were then adjusted to pH 2.5 and held at 
room temperature. PLL/DHBA (6 mg/mL, 10 mL) was transferred to the dialysis bag 
and immersed into the above solution. Samples were taken from the solution after 2 
hrs to study the metal concentration. 
Cytotoxicity of polymeric iron chelator: The cytotoxicity of polymers was determined 
by the CellTiter 96® Aqueous Cell Proliferation Assay (Promega). Human umbilical 
vein endothelial (HUVEC) cells and human lung adenocarcinoma epithelial (A549) 
cells were cultured and incubated with polymers for ~24 h. Next, the media was 
removed and replaced with a mixture of 100 µL of fresh culture media and 20 µL of 
MTS reagent solution and cells were incubated for 3 h at 37°C in a 5% CO2 
incubator.  The absorbance of each well was then measured at 490 nm using a 
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microtiter plate reader (SpectraMax, M25, Molecular Devices Corp.) to determine 
relative cell viability.  
In vitro hemolysis assay of the polymer: To determine the effect of polymer solution 
on red blood cell (RBC) aggregation, a hemolysis assay was performed using blood 
from mice. The erythrocytes were collected by centrifugation at 1500 rpm for 15 min, 
and then washed three times with 35 mL of phosphate buffered saline (PBS) buffer at 
pH 7.4. The stock solution was prepared by mixing 2 mL of centrifuged erythrocytes 
into 45 mL of PBS. The PLL/DHBA solutions were prepared in PBS buffer with four 
different concentrations (1 mg/mL, 100 μg/mL, 10 μg/mL, and 1 μg/mL). One 
hundred microliter of sample solution was added to 1 mL of the stock solution in a 
96-well plate. The solutions were incubated for 1 hr at 37 °C. The percentage of 
hemolysis was measured by UV–vis analysis of the supernatant at 570 nm absorbance 
after centrifugation at 3000 rpm for 1 hr. One milliliter of saline was used as the 
negative control.     
4.3 Results and Discussions 
The kinetics of metal binding was monitored in a 2 mg/mL FeCl3 solution.  The 
equilibrium binding was found to be 1303.7 mg/g for the PLL/DHBA iron chelating 
polymer.  The safe dose of DFO for adults and children is 15 mg/kg/h. This does 
chelates only 1.275 mg/kg/h. This means that the maximum Fe binding of DFO is 
~85 mg/g. 
98
 The high equilibrium binding of Fe by PLL/DHBA can offer a potential 
alternative for DFO. 
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Figure 4-18: Kinetic data (read from dialysate). 
 
More importantly, about 80% of the total absorption was attained in <5 min (Figure 
4-18, Table 4-7). The rate and duration of the response of non-transferrin-bound iron 
to chelation therapy are largely unknown and have important implications for the 
design of optimal chelation regimens. One problem with DFO is the slow rate at 
which it removes iron from transferrin, which is probably the most readily available 
pool of iron in the body.
99
 Such slow kinetics may limit the performance of DFO 
since it exhibits such a short half-life. This might become an important issue when 
using DFO as a chelator in patients with acute iron poisoning. The high affinity and 
rapid binding of iron by PLL/DHBA polymers may offer improvement in iron 
chelation therapy. This near instantaneous iron absorption behavior may be highly 
desired for treatment of acute iron overload.   
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Table 4-7: Percent absorption of Fe by PLL/DHBA polymer. Dialysis was conducted 
until equilibrium. 
Measured from % absorbed 
Retentate 85.85±0.025 
Dialysate 76.98±0.076 
 
 A multi-solute system was used to evaluate the metal selectivity of PLL/DHBA 
polymer.  At an equal concentration of all metals (2 mg/mL), PLL/DHBA absorbed 
almost 75% of the iron in the media, the highest of any metal present except for Ni, 
which may not be a concern since Ni normally has a lower concentration in blood 
((0.46±0.26)*10
-6
 mg/mL) (Figure 2).
100
 PLL/DHBA polymers were highly selective 
for iron and nickel over other essential elements present in the blood, (i.e. zinc and 
calcium), as desired.    
The application of DFO in iron overload diseases has been limited by its toxic 
properties. Its inherent hypotensive effect limits the amount of drug that may be 
administered in acute iron overload, with the intravenous infusion not to exceed 15 
mg/kg/hr or a total of 6.0 g in 24 hours.
101
 The chronic use of DFO results in some 
difficulties due to its short circulation half-life. Consequently DFO, which is not 
absorbed orally, must be administered by frequent intramuscular injection, continuous 
subcutaneous infusion, or more rarely by slow intravenous infusion.  
The use of PLL/DHBA may provide benefits by optimizing vascular retention. A 
relatively large molecular weight PLL will likely prolong plasma retention of 
PLL/DHBA. This may alter the dosage and frequency required for the treatment of 
acute and chronic iron overload disorders. 
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Figure 4-19: Selectivity study (read from dialysate). 
 
A cytotoxicity assay was used to study the effect of PLL/DHBA on HUVEC and 
A549 cells. DFO, an FDA-approved drug which is currently used for the treatment of 
iron overload disease, was used as a control.  PLL/DHBA showed almost no 
cytotoxicity on HUVEC cells at low to moderate concentrations while DFO was 
considerably cytotoxic even at concentrations as low as 10 μg/mL (Figure 4-20). Both 
PLL/DHBA and DFO had a negligible effect on A549 cells. Cell viability data 
exceeding 100% that was observed in this study is likely an indication of an increased 
cellular metabolic rate in the presence of low concentrations of polycations. 
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Figure 4-20: Cytotoxicity study conducted on (A) A549 cells and (B) HUVEC cells. 
 
 When charged or membrane-permeable polymers are injected into the blood, any 
detrimental interactions with blood constituents must be avoided. The effect of these 
polymers on red blood cells was studied at relatively high concentrations. 
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PLL/DHBA samples did not show any evidence of hemolytic activity over the 
experimental range (Figure 4-21).  
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Figure 4-21: Hemolytic activities of PLL and PLL/DHBA. 
 
4.4 Conclusion 
 A water soluble polymer that mimics the structure of enterobactin was 
synthesized. DHBA was conjugated to poly-L-lysine and the binding affinity and 
selectivity of the conjugate polymer was studied. Fe removal by this siderophore-
mimetic polymer was nearly instantaneous. Moreover, this bio-inspired polymer 
exhibited relatively high selectivity toward iron in the presence of other competing 
metals. PLL/DHBA and its conjugate with Fe also showed relatively low cytoxicity 
and was not hemolytic, thus further studies in vivo are justified. 
 
 
 
 
Chapter 5 
 
Thiol Modified Hydrogels: Potential Chelators  
for Toxic Metals 
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5.1 Introduction 
Heavy metals such as cadmium, lead and arsenic are highly toxic to living 
organisms.
102
 Wastewater discharge is a primary source of heavy metal release into 
the environment.
103
 The removal of heavy metal ions from industrial wastewater has 
been given much attention in the last decade, because such components can 
accumulate in living organisms.
104-105
 Upon their accumulation in the human body, 
these toxic metals may cause kidney failure, nerve system and bone damage, and 
other serious diseases.
106 
The necessity to reduce the amount of heavy metal ions 
from the environment has led to an increasing interest in technologies that selectively 
remove such toxic metals. 
Solvent extraction techniques are frequently employed for removal of selected 
metal species from aqueous solutions; however, this technology is not always 
desirable as it requires a large inventory of an organic solvent that is often flammable, 
toxic or otherwise hazardous.
107
  Membrane filtration is another method to remove 
toxic metals from waste water.
108
 Aside from their application in areas such as drug 
delivery and immobilization of enzymes, hydrogels have received attention in the last 
decade because of applications in the recovery of metals and metal pre-concentration 
for environmental analysis.
109
 Metal-coordinating resins and selectively absorbent 
polymers or copolymers have been extensively studied.
110-111
 
Because of the serious damage toxic metals may cause to the human body and to 
the environment, desirable polymeric ligands must possess high affinity, capacity, 
and selectivity towards the toxic metal of interest. Furthermore, such polymeric 
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ligands may have potential use in biomedicine if the polymers are non-toxic, well 
tolerated, and exhibit high capacity and selectivity for the toxic metal. 
 This work reports the synthesis of functionalized hydrogels capable of selectively 
removing toxic metals (i.e. Pb, Cd, As) from an aqueous solution.  Functionalized 
polyallylamine (PAAm) hydrogels have been introduced previously as potential iron-
specific chelating agents. Here, thioglycolic acids (TGA) in combination with the 
siderophore moiety dihydroxybenzoic acid (DHBA) were introduced onto PAAm and 
the binding capacity and selectivity of the hydrogels were investigated. Conjugation 
of the thiol groups dramatically improved the binding affinity and selectivity of the 
hydrogels for toxic metals. The rapid, high affinity binding of toxic metals by these 
functionalized hydrogels offers potential applications in waste water treatment and 
chelation therapy in patients suffering from acute poisoning.  
5.2 Materials and Methods 
Materials: Poly(allylamine hydrochloride) (PAAm) with an average molecular 
weight of 56 kDa and analytical grade reagent N,N’- methylenebisacrylamide (MBA) 
were obtained from Sigma-Aldrich and used without further modification. 2,3 
dihydroxybenzoic acid, thioglycolic acid (TGA), N,N,N -triethylamine (TEA), 
dimethylformamide (DMF), and all metal chlorides were purchased from Fisher 
Scientific and used as received. Dicyclohexylcarbodiimide (DCC) and N-
hydroxysuccinimide (NHS) were purchased from Thermo Scientific and used without 
further modification. Deionized water (DI) was obtained from a Barnstead EasyPure 
water purifier. 
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Preparation of PAAm Hydrogel PAAm hydrogel was synthesized following the 
procedure reported in the literature.
112
 Briefly, a 20% w/v polymer solution 
containing a predetermined amount of MBA was prepared. The cross-linker was 
dissolved in deionized water (flushed with nitrogen for 5 min) and then added to the 
polyallylamine polymer. TEA, the cross-linking catalyst (300 μL), was then added to 
the solutions and mixed thoroughly. Next, the precursors were transferred by pipet 
into small vials. The vials were held at ambient temperature for 1 h and then cooled to 
ca. 3 °C and held there for an additional 24 h. After this time, hydrogels were 
removed from the vial and washed with 0.05 M sodium chloride for several days.  
Functionalization of Hydrogel: A solution of TGA and NHS in 5 mL of DMF was 
mixed with a solution of DCC in 5 mL of DMF. The mixture was stirred at low 
temperature for 6 h to give a white precipitate. The precipitate was filtered, and the 
filtrate was added directly to a known mass of ground hydrogel. The reaction mixture 
was held at room temperature for 3 days. PAAm conjugate hydrogel was then washed 
with water for several days. The same procedure was done for the conjugation of 1:1 
molar ratio of TGA/DHBA. 
Quantification of Amine Functional Groups: Primary amine groups were quantified 
by potentiometric titration. After grinding to a powder, 40 mg of functionalized 
hydrogels were suspended in 35 mL of 0.2 M aqueous KCl solution. Next, 140 μL of 
8 M KOH aqueous solution was added to polymer suspensions to raise the pH to ~12. 
Standard 0.1 M HCl was used to titrate the suspension. HCl was added until the pH 
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was about 2.5 in all polymer suspensions. Free amine groups were quantified from 
potentiometric data following reported procedures.
113
 
Binding Kinetics Study: Metal chloride solutions (2 mg/mL) were adjusted to pH 2.5 
with ionic strength in the range of 0.02 M to 0.04 M and kept at room temperature for 
kinetic studies. Samples were taken from the media at different time intervals to 
determine the rate of metal binding by functionalized hydrogel. 
Binding Experiments: Known concentrations of metal chloride solutions (0.25, 0.5, 1, 
2, 2.5) mg/mL were prepared. Binding experiments were carried out by taking 20 mL 
of metal solution in 125 mL volumetric flasks. Solutions were adjusted to pH=2.5 
while maintaining metal concentration. Ionic strength of all solutions was between 
0.02 M to 0.04 M. Next, a known mass of functionalized hydrogel was added to the 
mixture and was held at room temperature for 2 h or until equilibrium was reached. 
The solutions were then filtered and the filtrates were analyzed for metal 
concentration. 
Adsorption isotherms: Different isotherm models were employed to determine how 
the metal molecules distributed between the liquid phase and the hydrogel phase 
when the adsorption process reached equilibrium. Langmuir, Freundlich, and Temkin 
isotherm models were applied to the data. Adsorption parameters for each metal ion 
were calculated at a pH value of 2.5. The constants for each isotherm model were 
calculated and the accuracy of the isotherm models were evaluated using linear 
correlation coefficient (R
2
) values. 
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Selectivity Study: The selectivity for Pb, Cd, and As by functionalized PAAm in the 
presence of competing metals was studied. A metal solution (10 mL, 2 mg/mL) 
containing all metal components was prepared. The solution mixture was then 
adjusted to pH 2.5 and held at room temperature for 2 h after adding a known mass of 
functionalized dry gel. Ionic strength of all solutions was between 0.02 M to 0.04 M. 
Metal Analysis: Mono- and multi-elemental analysis of samples was quantified by 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) (Optima 
2000 DV, PerkinElmer, USA) fitted with an AS 93plus autosampler (PerkinElmer, 
USA). A Cross-Flow nebulizer and a Scott spray chamber were used. The RF Power 
was 1300 W and nebulizer and auxiliary flows were 0.8 and 0.2 L/min, respectively. 
Sample flow was set at 1.5 mL/min. ICP-OES data was processed using Winlab 32 
(Ver. 3.0, PerkinElmer, USA). The analytical curves used for sample analysis had 
coefficients of correlation >0.999. 
5.3 Results and Discussion 
Synthesis and characterization: Poly(allylamine hydrochloride) was cross-linked 
following a previously reported method.
84
 Here, an optimized reaction yield was 
chosen from the previously reported data. 2,3 DHBA and TGA were covalently 
linked to available amino sites of PAAm hydrogel via DCC/NHC conjugation 
chemistry. Moreover, potentiometric titration data were used to calculate the degree 
of conjugation using the following equation (Figure 5-22). 
113
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               (5-1) 
  
Here, CH is the concentration of hydrogel. The conjugation efficiency was 
47% and 67% for PAAm/TGA and PAAm/TGA/DHBA hydrogels, respectively. 
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Figure 5-22: Titration data collected for PAAm/TGA and PAAm/TGA/DHBA. pH 
values represent the values of 3 readings differing by < 5%. 
 
Binding Kinetics: Determination of the kinetics of metal absorption is critical for 
elucidating the performance of hydrogels and for evaluating the potential for 
chemical and biomedical applications. The kinetics of metal binding was monitored 
by adding a known mass of dry hydrogels to a known initial concentration of metal 
solution (2 mg/mL, metal chloride). The concentration of metal in solution was 
monitored over time.  About 40%-50% of the total metal absorption was attained in 
less than 5 min for all functionalized hydrogels (Figure 5-23). 
( ) ( )HCl
H
C H OH
n
C
  

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Figure 5-23:  Ion binding by functionalized  hydrogels, A) Pb, B) Cd, and C) As. Gels 
were equilibrated in 2 mg/mL metal solution (pH= 2.5). Ionic strength values ranged 
from 0.02 M to 0.04 M. 
 
The absorption was fastest for As in the presence of the different functionalized 
hydrogels and slowest for Cd. This might be due to the smaller atomic radius of As 
compared to Pb and Cd. Previously, Ozay et al. synthesized composite hydrogels with 
magnetic properties and studied the hydrogels for the removal of toxic metal ions 
from aqueous environments. In all their case studies, less than 40% of the total metal 
was absorbed after 2 h. In most studies, the minimum required time to reach ~50% of 
the total removal was about 15-30 min.
114
 The rapid absorption behavior of hydrogels 
reported here may offer an important advantage, especially in biomedical applications 
such as the treatment of acute metal poisoning.
115
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 The equilibrium binding values were systematically higher for PAAm/TGA 
hydrogels compared to PAAm/TGA/DHBA (Table 5-8). 
Table 5-8: Maximum binding capacity of hydrogels at pH=2.5 when ionic strength 
varied between 0.02 M and 0.04 M. 
Metal ion 
PAAm/TGA 
(mg/g) 
PAAm/TGA/DHBA 
(mg/g) 
As 568 520 
Pb 345 291 
Cd 452 294 
 
This might be because of a high density of thiol groups available for coordinating 
with toxic metals. Tofan et al. have conducted a systematic study on Cd and Pb 
absorption kinetics for a metal-binding material produced by introducing sulphydryl 
functional groups into natural hemp fibers.
116
 The absorption capacity of modified 
hemp was reported to be 14.0 and 23.0 mg/ g of fibers for Cd and Pb ions, 
respectively at room temperature. In comparison, hydrogels reported here achieved ~ 
20 fold and ~ 10 fold higher binding capacity when using PAAm/TGA to bind Cd 
and when using PAAm/TGA/DHBA gels to bind Pb, respectively. 
To derive the rate constant and binding capacity, the kinetic data were modeled 
with pseudo-first-order (Lagergren model) and pseudo-second-order (Ho model) 
kinetic models which are expressed in their linear forms as: 
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               (5-2) 
2
2
1
t e e
t t
q q k q
                                          (5-3)  
where k1 (L/min) and k2 (g/mg · min) are pseudo-first-order and pseudo-second-order 
rate constants, respectively. The model variables obtained by linear regression were 
compared (Table 6-112). The pseudo-second order reaction model showed the best fit 
since it had a R
2
 value close to unity in each of these cases. 
 
Binding Isotherms: The metal ion binding capacity was determined and different 
isotherm models were used to fit the data. A low pH was selected for these studies 
because of the potential application of these hydrogels in acute metal poisoning 
(stomach pH ~2.5). The metal ion uptake was relatively high. This could be due to the 
presence of protonated primary amine groups along with thiol functional groups 
which together provided excellent coordination sites for metal binding.  
 
 
 
 
 
 
1ln ln q log
2.303
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k
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Table 5-9: Kinetic parameters for metal binding by functionalized hydrogels at 
pH=2.5. Ionic strength values ranged from 0.02 M to 0.04 M. 
 
Chelating hydrogel PAAm/TGA PAAm/TGA/DHBA PAAm/TGA PAAm/TGA/DHBA 
 
Metal ion 
    
R
2
 
As 
0.999 1 0.864 0.0466 
K 14.7 13.4 0.0100 N/A 
      R
2
 
Pb 
0.997 0.999 0.986 0.939 
K 16.0 5.46 0.0100 0.0203 
      R
2
 
Cd 
0.996 0.999 0.00360 0.521 
K 0.00380 1.079 N/A N/A 
Several theoretical isotherm equations, including those of Freundlich, Langmuir, and 
Temkin, were employed to evaluate which could best describe the experimental data. 
None of the three adsorption models provided an accurate fit for data reported in this 
study as low correlation coefficient values were observed (Table 5-10). In most cases, 
a reciprocal plot of the data gave a straight line fit for Langmuir isotherms but 
negative intercept values suggested that simple Langmuir adsorption did not occur. 
The Freundlich model assumes that there are many types of sites acting 
simultaneously, each with a different free energy of absorption, and that there is a 
large number of available sites. The negative cooperativity factor (n) below unity in 
this study is an indicator of heterogeneous absorption due to the negative lateral 
Ho model Lagregern model 
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interaction between absorbed metal and/or non-uniform binding affinities of hydrogel 
sites.
117-118
 
Table 5-10: Isotherm parameters for metal binding by functionalized hydrogels at 
pH=2.5. Ionic strength values ranged from 0.02 M to 0.04 M. 
Hydrogel TGA DHBA/TGA TGA DHBA-TGA TGA DHBA/TGA 
Isotherm model Pb Cd As 
Freundlich             
KF NA 1.027 NA NA 1.060*10
7
 16.7*10
2
 
n NA -2.16 NA NA 2.40 -0.516 
R
2
 0.141 0.778 0.455 0.228 0.875 0.926 
sen NA 0.122 NA NA 0.0784 0.273 
sey NA 0.142 NA NA 0.216 0.476 
Langmuir 
      qmax NA 0.890*10
2
 NA 81.7 664.5 -4.51 
KL NA -5.10 NA -2.79 32.2 62.9 
R
2
 0.0215 0.644 0.321 0.793 0.952 0.863 
sen NA 8.16*10
-4
 NA 0.00111 5.20*10
-6
 6.98*10
-4
 
sey NA 0.00301 NA 0.00215 4.057*10
-4
 0.00204 
Temkin 
      A NA 0.0814 NA NA 25.3*10
1
 NA 
b NA -33.5 NA NA 16.1 NA 
R
2
 0.101 0.611 0.176 0.356 0.695 0.365 
sen NA 29.4 NA NA 50.6 NA 
sey NA 78.7 NA NA 13.9*10
1
 NA 
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The Temkin isotherm assumes that a decrease in the heat of adsorption is linear and 
that the absorption is characterized by a uniform distribution of binding energies. This 
model did not fit data either, suggesting that multiple, complex binding mechanisms 
may be involved in metal absorption.  
Selectivity Studies: An important feature of metal chelating hydrogels is the ability to 
specifically target the metal of interest and remove it from the media. The metal 
selectivity of PAAm/TGA and PAAm/TGA/DHBA hydrogels was investigated using 
a multi-solute system. At an equal concentration of all toxic metals (i.e. Pb, Cd, As at 
2 mg/mL), PAAm/TGA absorbed almost 100% of the lead present in the media while 
in the same experiment and in the presence of other competing metals such as Fe and 
Zn this value decreased to ~70% (Figure 5-24). The tendency of PAAm/TGA 
hydrogel for absorption of metals followed the order of Pb > As> Cd> Zn> Fe. This 
trend was similar for PAAm/TGA/DHBA. Previously a high Pb removal capacity 
using magnetic hydrogels (130 mg/g) has been reported.
115
 The Pb removal capacity 
with PAAm/TGA and PAAm/TGA/DHBA was 345.6 and 291.7 mg/g, respectively. 
All data suggested that these hydrogels may have excellent potential in waste water 
treatment and probable application in acute metal poisoning. 
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Figure 5-24: Selectivity study of functionalized hydrogels toward toxic metal ions A) 
in the presence of competing toxic metals and B) in the presence of competing 
essential metals (pH=2.5). 
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5.4 Conclusions 
Cross-linked polymers with different functional groups were designed for removal of 
toxic metals. Dihydroxybenzoic acid and thioglycolic acid were used as conjugated 
moieties to improve the affinity and selectivity of PAAm toward toxic metals. These 
hydrogels were able to remove and accumulate Pb, Cd and As ions from aqueous 
solutions at relatively low metal concentrations. PAAm/TGA and 
PAAm/TGA/DHBA hydrogels demonstrated an almost instant metal absorbance 
when equilibrated in the metal solution. The pseudo-second order Ho kinetic model 
offered an excellent fit to absorption data. The inclusion of thiol groups to hydrogels 
seemed to improve selectivity toward Pb and As. The rapid binding and selectivity of 
these functionalized hydrogels for toxic metals provides important features for waste 
water treatment and may enable applications in acute metal poisoning.  
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
Magnetic Polyvinylamine Nanoparticles by In Situ 
Manganese Substitution 
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6.1 Introduction 
Magnetic nanoparticles with high magnetization saturation have received attention 
because of exciting new applications in biomedicine as well as more traditional 
applications such as magnetic data storage.
119
 Spinel ferrites have been intensively 
studied in recent years because they show high magnetic permeability and low 
magnetic losses.
120-121
 There are a variety of transition metal cations that can be 
incorporated into the lattice of the magnetite structure such as Mn, Co, Ni, Mg, and 
Zn. Manganese ferrite (MnFe2O4), has emerged as an important superparamagnetic 
material that has been widely studied in magnetothermal therapy, in contrast-
enhanced magnetic resonance imaging (MRI) and in sustainable energy research.
122
 A 
recurrent problem with these metal ferrite nanoparticles, however, is the hydrophobic 
surface which often leads to agglomeration if stored as a colloid or if introduced in 
vivo.
123
 Agglomeration is suspected to increases the probability for clearance by 
macrophages and the risk of unwanted occlusions.
124-125
 Furthermore, agglomeration 
of manganese ferrite nanoparticles reduces the superparamagnetic properties.
126
 Other 
problems commonly occurring during the synthesis of manganese ferrite include the 
wide particle size distributions and a lack of well-defined crystal structure.
127
 
To overcome these difficulties a practical route to monodisperse, stable MnFe2O4 
nanoparticles is needed. Also, reactive sites for the conjugation of complex biological 
molecules such as pharmaceuticals or targeting moieties are desirable.
128-129
 A 
commonly used procedure for making MnFe2O4 particles has been the co-
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precipitation of Mn
2+
 and Fe
3+
 ions under basic conditions, usually NaOH in an 
aqueous solution or in an inverse micelle template.
130-131
  Researchers have been 
studying different techniques such as engineering the surface of manganese ferrite 
nanoparticles or applying a size selection process at the end of the synthesis 
procedure to overcome the mentioned difficulties.
123
 However, these methods are 
often ineffective, labor intensive, and can exhibit low yields. 
Recently, we reported a convenient procedure for making monodisperse magnetic 
polyvinylamine nanoparticles through the in situ reaction of FeCl3 and FeCl2 within 
cross-linked polyvinylamine nanoreactors.
132
 Results indicated that magnetic PVAm 
nanoparticles with a size around 100 nm had a saturation magnetization of ~30 emu/g 
of iron oxide, and narrow size distribution. PVAm nanoparticles had a size ~200 nm.  
Here, the synthesis and characterization of MnFe2O4 incorporated in PVAm 
nanoparticles is reported as an approach to increase the magnetization of magnetic 
PVAm. Amine groups within polyvinylamine nanoparticles were utilized to bind 
manganese and iron ions. Metal ion concentration was adjusted to obtain the 
stoichiometric ratio within nanoparticles required for the co-precipitation reaction. 
The final magnetic nanoparticles were ~ 50 nm in diameter, offered colloidal 
stability, and exhibited a narrow size distribution (polydispersity~ 0.134). Moreover, 
the magnetization saturation increased by 60% when compared to magnetite 
containing PVAm nanoparticles.  
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6.2 Materials and Methods 
Materials: N-vinylformamide (NVF; Aldrich) was used as a monomer without further 
modification, and 2, 2’-Azobis (2,4-dimethylpentanitrile) (Vazo-52, purchased from 
DuPont) used as an initiator for the polymerization reaction of N-vinylformamide. 
Deionized water (DI) was obtained from a Barnstead EasyPure water purifier. Ferric 
chloride, manganese chloride, hexane, Span 80, Tween 80, and sodium hydroxide 
(purchased from Fisher Scientific) were all used as received. 2-(N-Vinylformamido) 
ethyl ether (NVEE), a derivative of NVF, was synthesized in our lab and used as a 
cross-linker. 
Synthesis of polyvinylamine Nanoparticles: Cross-linked PVAm nanoparticles were 
produced following the same procedure reported previously.
132
 Briefly, cross-linked 
PNVF nanoparticles were fabricated by inverse microemulsion polymerization of 
monomer (NVF) with cross-linker (NVEE).  Subsequently, the PNVF nanoparticles 
were hydrolyzed using 0.1 M NaOH solution for 2 hrs to produce PVAm 
nanoparticles.   
Fabrication of magnetic polyvinylamine Nanoparticles: To synthesize MnFe2O4, the 
following reaction should be performed in an aqueous solution using a molar ratio of  
Mn 
II
 : Fe 
III
 ~ 0.5.
133
 
4232 2 OMnFeFeClMnCl   
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In a representative experiment, MnCl2 (3.95 g, 0.02 mol) and FeCl3 (5.2 g, 0.019 
mol) were dissolved in 25 mL of deoxygenated PVAm nanoparticle suspension (5 
mg/mL). This mass ratio was determined experimentally to yield roughly a 0.5 ratio 
of MnCl2 : FeCl3 within nanoparticles.
134
 The solution was stirred for 2 h at room 
temperature. Next, the solution of PVAm nanoparticles containing MnCl2 and FeCl3 
was transferred to a centrifuge tube and centrifuged for 30 minutes at 15,000 rpm. 
The pellet was re-dispersed in deoxygenized water. The re-suspended pellet was 
added drop-wise into 50 mL of 1.5 M NaOH solution with rate of 10 mL/min under 
vigorous stirring. The last step generated a black/brown suspension of magnetic 
PVAm nanoparticles almost instantly.  Langmuir (1) and Freundlich (2) binding 
kinetics were observed while saturating PVAm nanoparticles with required 
concentrations of metal ions, 
KC
KC



1
max
                      (1-6) 
nKC
m
x
1
                           (2-6) 
where K and 1/n are constants for a given absorbate and absorbent at a particular 
temperature, Г is amount absorbed, C is an equilibrium aqueous concentration, x is 
mass of absorbate and m is mass of absorbent. 
After the co-precipitation reaction was carried out, the suspension was put into a 
sealed, temperature-controlled reaction vessel for aging. It has been reported that the 
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pH value, aging temperature and aging time affect the MnFe2O4 particle size and 
morphology.
135-136
 The suspension was then aged at 90 °C for 45 or 90 min. The 
particles were isolated using a magnetic field and the supernatant was removed. 
Deoxygenated water was then added to re-disperse the magnetically collected 
particles and the solution was centrifuged at 15,000 rpm for 30 min. 20 mL of 0.1 M 
HCl solution was added to the precipitate under stirring to re-disperse the magnetic 
pellet in centrifuge tubes. The resulting opaque/brown suspension was then washed 
with PBS (pH~ 9) and then with PBS (pH 7.4) using similar centrifugation and re-
dispersion cycles. 
Transmission electron microscopy studies: The size and morphology of magnetic 
nanoparticles were observed by transmission electron microscopy (JEOL 1200 EXII) 
at 200 kV. In addition, energy dispersive X-ray spectroscopy (EDX) was used to 
confirm the manganese and iron presence inside PVAm nanoparticles. The powder 
was re-suspended in water and drop-cast onto a 300 mesh carbon-coated copper grid 
that was air dried before imaging.  
Iron and Mn content measurement within PVAm Nanoparticles: Parameters of 
Langmuir and Freundlich equation were determined by calculating the concentration 
of Mn and Fe absorbed by PVAm particles at various initial concentrations. These 
concentrations along with the final concentration of MnFe2O4 in magnetic PVAm 
nanoparticles were measured by atomic absorption spectroscopy (AA) using a Perkin 
Elmer Analyst 300 with a AS90 plus auto sampler. The suspension of magnetic 
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PVAm was diluted with HNO3 (0.1% v/v).  A regular sensitivity nebulizer without an 
impact bead was installed as well as a 10 cm single slot burner head.   The analysis 
was conducted using a Perkin Elmer Fe/Mn multi tasker bulb. 
Magnetic measurements: The magnetization of PVAm containing manganese ferrite 
with different Mn:Fe initial ratio were studied at room temperature (magnetic field 
between -20 and 20 kOe) using a Quantum Design MPMS 5 superconducting 
quantum interface device (SQUID) magnetometer. Mass magnetization is defined as 
the magnetic moment per total mass of the sample. 
6.3 Results and Discussions 
Synthesis of Magnetic PVAm: PVAm is a water-soluble polymer which has stable 
primary amine functionality along its backbone and may be partially or fully 
hydrolyzed to impart a low or high density polycation, respectively. This polymer has 
been employed in industrial applications such as water treatment, adhesives, 
industrial coatings, ion exchange resins, etc. The high reactivity of amino groups 
provides important active sites for cross-linking and ion exchanging.
137
 To synthesize 
magnetic PVAm nanoparticles containing MnFe2O4, a co-precipitation reaction was 
performed within PVAm nanoparticles. As reported previously, this approach utilizes 
the chelating property of primary amine groups presented in PVAm nanoparticles to 
bind iron and manganese ions.
132
 The co-precipitation reaction is then carried out to 
form metal oxides which are retained inside crosslinked PVAm nanoparticles. 
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The binding affinity of PVAm nanoparticles was determined as a means to 
calculate concentrations required to maintain the stoichiometric ratio for the co-
precipitation reaction. Traditional Langmuir and Freundlich models were used to fit 
the metal ion concentration data obtained from atomic absorption spectroscopy. 
Fitting parameters were calculated and applied to isothermal Freundlich and 
Langmuir models (Figure 6-25 and Table 6-11). 
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Figure 6-25: Freundlich (A) and Langmuir (B) isotherm plots for Fe and Mn 
absorption by PVAm. 
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Table 6-11: Fitted affinity parameters using Langmuir and Freundlich models. 
Model Parameter Correlation R 
Freundlich 
Fe:  KD = 0.71 mg
-1.05
mL
1.05
; n 
= 1.05 0.9988 
Mn: KD = 0.72 mg
-1.03
mL
1.03
; n 
= 1.03 
0.9945 
 
Langmuir 
Fe:  KD = 0.02 mg
-1
mL;  
Cm = 59.88 mgmL
-1
 
0.9995 
Mn: KD  = 0.01 mg
-1
mL;  
Cm = 149.25 mgmL
-1
 
0.9998 
 
  
The traditional Freundlich model allows for the description of a broad range of 
affinity interactions. Here, a deviation of the theoretical curve from the experimental 
data was found. In contrast, the classical Langmuir isotherm model produced a 
theoretical curve, which was in better agreement with the experimental data. Data 
from binding studies showed that the binding constant of the PVAm/Fe complex was 
almost twice that of the PVAm/Mn complex. Values were used to predict the initial 
concentration of each metal ion required for maintaining the 1:2 molar ratio of Mn: 
Fe inside nanoparticles. Based on absorption isotherms, a 1:1 molar ratio of metal 
salts are required in PVAm nanoparticle suspension to obtain the 1:2 ratio of Mn: Fe 
inside PVAm nanoparticles. 
 In the next step, a co-precipitation reaction was carried out inside PVAm 
nanoparticles loaded with metal ions to yield manganese ferrite nanoparticles. The 
loading efficiency of iron oxide generated within PVAm nanoparticles was previously 
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found to be 12% (w/w). Here, the loading efficiency of manganese ferrite was >18%; 
an increase in loading of more than 66%. Studies have shown that the solubility of 
iron oxide increases as the pH decreases; therefore, the presence of HCl in the 
nanoparticle purification process may be a reason for the low loading of iron oxide 
previously.
138
 The improvement in the loading yield of manganese oxide in 
comparison to iron oxide may be explained by the fact that low pH might not be as 
effective in dissolving manganese ferrite particles, thus, improving retention of the 
metal oxide. 
Several methods have been reported for the synthesis of a stable manganese 
ferrite colloid. Keng et al. have reported a high temperature organometallic synthesis 
procedure of MnFe2O4.
139
 This method was based on thermal decomposition of 
Fe(CO)5 and Mn2(CO)10 in the presence of oleic acid. FeMn alloy nanoparticles were 
formed followed by oxidation with trimethylamine-N-oxide. The reaction resulted in 
highly crystalline and nearly monodisperse nanoparticles (less than 10% standard 
deviation), but very high temperatures were required to perform the reaction. Sun et 
al. have used a hot injection method to synthesize MnFe2O4 nanoparticles.
140
 They 
reported a high-temperature reaction of iron (III) acetylacetonate and manganese (II) 
acetylacetonate with 1,2-hexadecanediol in the presence of oleic acid and oleyl 
amine. This high temperature procedure yielded polydisperse nanoparticles and 
required size selection to achieve the desired particle size. Compared to the reported 
methods for preparing stabilized colloidal suspensions of manganese ferrite 
nanoparticles, the synthetic procedure reported here was simple since colloidal 
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stabilization persisted during the manganese ferrite synthesis and the final product did 
not require any further size-selection process 
Characterization of the particles: The morphology of PVAm/MnFe2O4 particles was 
studied by transmission electron microscopy (TEM). TEM images of 
PVAm/MnFe2O4 nanoparticles at different time intervals were obtained after aging at 
90 °C. Image analysis software determined that dry PVAm/MnFe2O4 nanoparticles 
were roughly 50 nm in diameter (Figure 6-26).  
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Figure 6-26: TEM images of PVAm/MnFe2O4 aged 45 min (A,B) and 90 min (C,D). 
 
Magnetic nanoparticles exhibited a reduction in particle size as a result of the 
reaction while compared to PVAm nanoparticles. Since many of the primary amine 
groups presented in PVAm nanoparticles were occupied by iron and manganese ions, 
the overall particle charge decreased resulting in a corresponding decrease in particle 
size as well. Dynamic light scattering studies confirmed that PVAm and magnetic 
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PVAm nanoparticles had low polydispersity, 0.134 and 0.159 respectively. Dark 
spots were also evident inside PVAm nanoparticles which were fabricated using 
different aging times (Figure 6-26). Diffuse dark areas were formed after 45 min of 
aging and punctuate dark spots resulted after 90 min. Dark spots inside the PVAm 
nanoparticles suggested the presence of small manganese ferrite nanoparticles (<7 
nm). 
Published reports have shown that non-aged MnFe2O4 particles may be 
amorphous, independent of reaction conditions.
141
 After aging, particles transition to 
a cubic crystal structure. Depending on aging time, the size and shape of manganese 
ferrite nanoparticles might vary. Researchers have reported similar observations for 
other types of magnetic nanoparticles.
142 
X-ray diffraction spectra of the 
PVAm/MnFe2O4 nanoparticles after 45 minutes of aging revealed several peaks, all 
of which corresponded to MnFe2O4 (Figure 6-27). Conversely, studies have shown 
that the spectrum for non-aged particles has two broad peaks, with complete 
crystallization usually not observed until the temperature exceeded  400 °C.
143-144
 The 
relatively low intensity of the peaks can be explained by the low mass fraction of 
manganese ferrite present in PVAm nanoparticles (<20%). Energy dispersive X-ray 
spectroscopy (EDX) also provided direct evidence of the presence of both Mn and Fe 
within PVAm nanoparticles (Figure 6-27). 
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Figure 6-27: XRD spectra of PVAm/MnFe2O4 nanoparticles (3A) and EDX spectra 
of PVAm/MnFe2O4 nanoparticles (3B) aged at 90 °C for 45 min.  
 
  
Magnetization Study: Relative magnetization curves were determined as a function of 
magnetic field strength for PVAm/MnFe2O4 nanoparticles (Figure 6-28). The 
magnetic PVAm nanoparticles exhibited a high magnetic moment when placed under 
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a high strength magnetic field. The magnetization curve exhibited zero magnetization 
upon the removal of magnetic field, which is a characteristic behavior of 
superparamagnetic particles. The saturation magnetization of PVAm/MnFe2O4 
particles with a 1:2 Mn:Fe ratio was ~40 emu/g of MnFe2O4. 
A
B
C
 
Figure 6-28: Magnetization vs. applied magnetic field for PVAm/MnFe2O4 with (A) 
1:2 and (B) 1:4 stoichiometric ratios compared to (C) PVAm/Fe3O4
.
 
 
 This value was smaller than the reported bulk saturation magnetization value of 
manganese ferrite (~ 80 emu/g of manganese ferrite) but was still significantly higher 
than the saturation magnetization observed for PVAm/Fe3O4 (~30 emu/g of iron 
oxide) nanoparticles.
127, 132
 Studies have shown that magnetic nanoparticles with 
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saturation magnetization as low as 20 emu/g of iron oxide, offer potential use as MRI 
contrast agents.
145  
6.4 Conclusions 
In situ synthesis of manganese ferrite within polyvinylamine nanoparticles offers an 
alternative to ligand grafting, surfactants, or encapsulation of manganese ferrite 
nanoparticles to aid transfer to water.
146
 The chelating property of primary amines in 
PVAm nanoparticles was utilized to hold iron and manganese ions inside the 
polymeric network. An in situ co-precipitation of stoichiometric ratios of ferric and 
manganese ions was then carried out followed by aging the manganese ferrite inside 
PVAm particles. This method yielded crystalline manganese ferrite within 
monodisperse nanoparticles while maintaining colloidal stability. The method 
reported was simple, efficient and did not require further size selection. Moreover, 
PVAm/MnFe2O4 nanoparticles possess reactive primary amines that may be modified 
to enable targeted delivery of this contrast enhancing agent. 
 
 
 
 
 
 
 
 
 
Chapter 7 
Conclusion and Future work 
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Metal chelating polymers have many applications in medicine and in industry. 
Physical and chemical design properties such as side chain functionality and 
molecular weight make polymers promising materials for use as therapeutic agents, 
drug delivery systems, and industrial devices.
19
 Metal chelating polymers have been 
used in tissue engineering, and as components of medical devices. Another ongoing 
application of chelating polymers is drug delivery of active pharmaceutical 
ingredients such as proteins, antibodies, plasmid DNA and siRNA. Nonetheless, there 
have been few reports on the application of metal chelating polymers as a drug.  
The aim of this work has been to design and fabricate biologically inspired 
polymers to selectively bind iron or toxic metals. Iron-binding polymers can be 
specifically used as chelating agents in patients with iron overload diseases. The 
enterobactin, a potent, naturally occurring Fe (III) chelator, was used as a design 
model for synthesis of a siderophore-mimetic polymer. 2,3 dihydroxybenzoic acid 
was immobilized on polyallylamine hydrogel to mimic the structure of this naturally 
occurring chelator. The metal binding affinity, kinetics and selectivity of hydrogels 
were studied. Result suggested that the conjugate hydrogels were able to remove and 
accumulate ferric and ferrous ions from aqueous solutions at relatively low metal 
concentrations. Moreover, 2,3 DHBA conjugate hydrogel demonstrated an almost 
instant iron absorbance when equilibrated in ferric solution. These siderophore-
mimetic hydrogels also exhibited a high affinity and selectivity for iron at different 
pH values.  
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Several ratios of PAAm:DHBA were investigated to optimize the stability 
constant, selectivity and binding capacity of siderophore-mimetic hydrogels. The 
hydrogel with ~15% DHBA exhibited the highest stability constant while maintaining 
selectivity and a high binding capacity for Fe (III). The high affinity and selectivity of 
PAAm-DHBA hydrogel for iron provides important features for this hydrogel in the 
treatment of iron overload disease such as hemochromatosis. Other conjugation 
moieties, such as TGA, were used to enhance the selectivity of PAAm toward toxic 
metal, i.e. Pb, Cd, and As.  Conjugate polymers bearing thiol functional groups 
showed high affinity and selectivity for toxic metals. 
Metal binding polymers were also explored as blood borne iron chelators. 2,3 
DHBA was conjugated to poly-L-lysine and the binding affinity and selectivity of the 
conjugate polymer was studied. The Fe removal by this siderophore-mimetic polymer 
was almost instant.  PLL/DHBA and its conjugate with Fe also showed relatively low 
cytoxicity. Moreover, PLL/DHBA did not significantly rupture or perturb RBCs. 
Metal binding polymeric nanoparticles were also used as a platform for MR 
imaging.  In situ synthesis of manganese ferrite within polyvinylamine nanoparticles 
offered an alternative to ligand grafting, surfactants, or encapsulation of manganese 
ferrite nanoparticles. Iron and manganese were held within polymeric nanoparticles 
using the chelating property of primary amines of PVAm. Monodisperse PVAm 
nanoparticles were successfully used to template crystalline manganese ferrite. 
PVAm/MnFe2O4 nanoparticles possessed colloidal stability and offered reactive 
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primary amines that may be modified to enable targeted delivery of this contrast 
enhancing agent. 
Future work with these siderophore-mimetic polymers should further examine the 
potential use of these polymers as therapeutic agents. This would include 
investigating the binding affinity, selectivity and kinetic of these polymers at several 
initial metal concentration and at appropriate conditions to mimic the physiological 
compartment. Evaluating the effect of DHBA molecules between 15%-80% graft 
density might help to further optimize Fe chelation. Moreover, animal studies are of 
interest to further investigate the performance of these polymers.  
For animal studies, the initial iron concentration in blood should be measured 
before starting the experiment. Models should be provided with a diet containing high 
levels of iron. Experimental groups should then be fed ground hydrogel for 4 days to 
allow clearance of untreated intestinal contents. Urine and blood samples should be 
collected from each animal for a period of either 48 h during days 3 and 4 or 24 h 
during day 4 only. Whole iron levels in the blood and urine should be measured ICP-
MS.  
For the injectable polymer chelator (PLL-DHBA), estimating the stability 
constant of soluble polymer with Fe would provide important information regarding 
its potential use as an alternative to DFO. The flexible structure of PLL-DHBA is a 
likely reason for the fast complexation kinetics of this polymer toward iron. Overall, 
multivalent, flexible molecules may be more effective in coordinating with metal ions 
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than single molecules; especially when the single molecule must fold or bend to 
provide the necessary binding sites. 
Another therapeutic use for synthetic siderophore-mimetic polymers is as 
antibiotics or as adjunct therapy. Siderophores and siderophore analogues can act as 
antibiotic agents through several different mechanisms. A biologically inactive 
chelator may deprive pathogenic microbes of essential iron. This iron starvation can 
be achieved through a decrease in local iron concentration though competitive 
chelation.  
Iron-binding polymers may also be explored in the removal of Fe from the lung. 
Iron can enter the lung by inhalation (i.e. cigarette smoke or metallic dust) or by 
catabolism of hemoglobin after alveolar hemorrhage.  Iron deposition in the lung is 
associated with tissue injury and fibrosis. The source of the iron that accumulates in 
the lung after exposure to cigarette smoke has not been identified. The metal could 
originate from either the cigarette or the host. Tobacco has been reported to contain 
150 µg iron/g.
147
 Only a small amount of this iron (0.1%) enters mainstream smoke, 
and this quantity is not considered significant.
148
 Alternatively, host sources of iron 
could be bound by the particulate matter surface after its deposition in the lung. Such 
complexation of host iron by cigarette smoke particles is likely to alter iron 
homeostasis, both in the lung and systemically. Treatment with iron chelators prevents 
lung injury both in animal models and in human disease caused by toxic iron that has 
entered the lungs via smoke inhalation.  Because of the detrimental effects of chelating 
agents on the vital organs in the human body, it is of great interest to find a new 
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technology to eliminate the excess iron (or other toxins) without systemic exposure to 
such treatments. Iron-binding polymers delivered to the lung can be used as an 
alternative chelator to remove Fe from the lung in smoker patients suffering from iron 
overload. 
Waste water treatment is another significant area of interest in the application of 
metal-binding polymers. Future work should offer more efficient and selective toxic 
metal binding by polymers through the modification of functional side groups. 
Moreover, renewable polymers capable of selectively and effectively binding toxic 
metals at low concentration may find applications in the water treatment industry. 
Further studies should address the recycling efficiency of metal-binding polymers. 
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